Abnormal serum enzyme levels

R18_ABNORMAL_SERUM_ENZYME_LEVELS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R74 Cause of death: ICD-10 — R74 2 out of 7 registries used, show all original rules.	15768
4. Check minimum number of events None	15768
5. Include endpoints None	15768
6. Filter based on genotype QC (FinnGen only)	14206

Control definitions (FinnGen only)

Control exclude: R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R7
Name in latin: Activitas abnormis enzymorum sanguinis

NAME	R18_ABNORMAL_SERUM_ENZYME_LEVELS
CONTROL_EXCLUDE	R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R74
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R74
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Abnormal serum enzyme levels based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14206	2414	11792
Unadjusted period prevalence (%)	4.63	0.86	5.41
Median age at first event (years)	65.16	55.85	67.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14688: Matched controls
141676

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N40

ICD-10 Finland

Hyperplasia of prostate

1.9

313.1

6549

41684

Y06

ICPC

Prostate symptom/complaint

3.6

307.7

1276

3636

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

4935

26198

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

72.5

307.7

2635

426

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

20.1

307.7

6415

5268

L02AE02

ATC

leuprorelin; implant, parenteral

7.6

307.7

2903

4455

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.8

307.7

1220

3327

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

6.3

307.7

1241

2036

TKE00

NOMESCO Finland

Needle biopsy of prostate

8.6

307.7

2598

3460

C61

ICD-10 Finland

Malignant neoplasm of prostate

11.4

307.7

7390

11587

116

Kela drug reimbursment

Prostate cancer

8.5

307.7

4166

6326

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

5.7

307.7

868

1545

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

11.0

307.7

7073

11045

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

8.0

307.7

583

725

TKE10

NOMESCO Finland

Puncture of prostate

17.6

307.7

479

271

L02BB03

ATC

bicalutamide; oral

5.0

307.7

1214

2485

XKD00

NOMESCO Finland

Uroflowmetry

3.4

307.7

5995

23720

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

9.8

307.7

1673

1827

L02AE04

ATC

triptorelin; parenteral

8.5

307.7

704

830

G04CA02

ATC

tamsulosin; oral

2.0

307.7

6817

43271

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

12.2

307.7

984

831

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

5.7

307.7

808

1444

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

3.4

307.7

3719

12821

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

5.7

307.7

731

1299

J01MA02

ATC

ciprofloxacin; systemic

2.0

307.7

6855

43822

Y77

ICPC

Malignant neoplasm prostate

7.0

307.7

2010

3129

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

136.8

307.7

728

KC1GB

NOMESCO Finland

Cystography with X-ray

7.8

307.7

485

621

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

8.0

307.7

640

803

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.4

307.7

5163

19596

XJH00

NOMESCO Finland

Transanal ultrasonography

3.4

307.7

2252

7159

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1219.6

307.7

11775

468

WF002

NOMESCO Finland

Radical radiotherapy

6.8

307.7

3006

5148

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

4.6

306.6

756

1637

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.7

275.7

665

1413

J01EA01

ATC

trimethoprim; systemic

2.2

272.6

3009

15128

ZX090

NOMESCO Finland

Other technic of radiotherapy

4.7

272.3

658

1400

ZXC96

NOMESCO Finland

Robot assisted procedure

4.1

270.0

793

1963

A05AA02

ATC

ursodeoxycholic acid; oral

7.1

269.3

415

576

L02BB04

ATC

enzalutamide; oral

5.7

257.2

493

855

XX3DW

NOMESCO Finland

Time consuming IT work

2.3

250.1

2132

9611

L02BX02

ATC

degarelix; parenteral

5.1

241.6

523

1013

WF090

NOMESCO Finland

Profylactic radiotherapy

8.5

226.6

298

343

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

225.0

5687

37267

163

Kela drug reimbursment

Abiraterone and enzalutamide

5.3

224.1

463

860

Z3231

NOMESCO Finland

Registered nurse

1.8

219.8

4395

26826

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

6.8

217.4

347

500

Z2221

NOMESCO Finland

Medical doctor

1.8

206.3

3951

23716

TKC52

NOMESCO Finland

Patient education concerning pelvic floor contraction exercises

21.7

205.4

156

R4110

NOMESCO Finland

Physiotherapy

1.8

194.0

4300

26867

L02BX03

ATC

abiraterone; oral

5.6

187.4

368

652

OAB42

NOMESCO Finland

Guidance related to known health problem

9.5

185.1

223

229

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

5.4

184.9

374

681

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.7

177.9

586

1568

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

9.4

170.9

207

214

G04BE03

ATC

sildenafil; oral

4.0

170.4

511

1280

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

6.6

169.2

280

419

352

Kela drug reimbursment

Abiraterone and enzalutamide

5.3

166.7

345

641

K76.9

ICD-10 Finland

Liver disease, unspecified

5.4

161.1

327

597

3054, ,

Kela drug reimbursment

5.8

160.4

299

504

1523, ,

Kela drug reimbursment

5.8

159.8

299

506

WX402

NOMESCO Finland

General anaesthesia

1.7

157.6

3362

20568

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

3.6

152.2

527

1457

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

150.2

3599

22691

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

146.1

2662

15513

K62.7

ICD-10 Finland

Radiation proctitis

5.9

145.2

266

441

G04BE30

ATC

drugs used in erectile dysfunction - combinations

9.2

135.9

167

176

UKC02

NOMESCO Finland

Cystoscopy

1.7

130.8

3251

20580

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

7.3

128.6

191

254

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

126.0

1509

7646

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.7

120.2

281

580

R31

ICD-10 Finland

Unspecified haematuria

1.8

120.2

2234

13022

ZXC20

NOMESCO Finland

Use of chemical agents

3.6

118.7

412

1140

G04BE01

ATC

alprostadil; parenteral, urethral

3.0

118.7

558

1858

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

117.6

469

1418

K74.3

ICD-10 Finland

Primary biliary cirrhosis

9.3

116.8

143

150

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

7.1

116.3

177

242

WX704

NOMESCO Finland

Intubation

2.0

116.0

1305

6456

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.0

110.0

519

1731

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

8.1

108.2

147

176

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

12.0

108.1

111

ZX080

NOMESCO Finland

Image guided radiotherapy

3.7

106.2

352

944

A98

ICPC

Health maint/preventive medicine

2.1

105.1

13750

123917

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.5

105.0

707

2828

KE1CG

NOMESCO Finland

Extensive MRI of prostate

4.2

104.6

283

656

M05BX04

ATC

denosumab; parenteral

2.3

102.9

790

3352

8148/2-C61.9

ICD-O-3

Glandular intraepithelial neoplasia, high grade of prostate gland

11.5

102.7

108

N02BE01

ATC

paracetamol; systemic, rectal

1.7

100.9

12620

111032

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.0

100.1

217

420

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

7.8

98.3

138

172

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

98.1

4984

36618

B01AB05

ATC

enoxaparin; parenteral

1.5

97.1

4457

32076

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

97.0

1053

5130

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

3.1

93.8

405

1283

G04CA01

ATC

alfuzosin; oral

1.5

90.0

3062

20633

K75.4

ICD-10 Finland

Autoimmune hepatitis

14.2

88.3

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.7

87.5

477

1718

2BX02, ,

NOMESCO Finland

13.6

87.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

87.2

2049

12637

N02AX02

ATC

tramadol; systemic, rectal

1.4

84.3

6181

48184

UJF32

NOMESCO Finland

Coloscopy

1.5

84.2

3781

26934

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

4.7

84.0

197

408

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

83.8

2022

12544

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

4.4

83.3

214

477

JN4BD

NOMESCO Finland

Extensive body CT

1.7

82.5

1647

9719

TKC22

NOMESCO Finland

Catheterisation instruction

2.4

81.1

564

2287

Z3226

NOMESCO Finland

Physiotherapist

1.6

80.1

2383

15531

L02BX04

ATC

relugolix; oral

8.8

79.1

101

112

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

8.8

78.0

109

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

77.5

1869

11575

KE1BG

NOMESCO Finland

MRI of prostate

3.3

77.4

303

905

Z71.8

ICD-10 Finland

Other specified counselling

1.4

76.4

4156

30592

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

75.8

3589

25736

R33

ICD-10 Finland

Retention of urine

1.7

74.4

1695

10342

G04CB02

ATC

dutasteride; oral

1.6

73.9

1938

12243

ZX112

NOMESCO Finland

Subcutaneous

2.8

73.0

365

1256

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

6.7

72.4

116

168

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

71.2

1183

6613

R74

ICD-10 Finland

Abnormal serum enzyme levels

8.5

70.4

105

ZXA05

NOMESCO Finland

Left side

1.5

70.3

3224

22927

WX720

NOMESCO Finland

Own respiration

2.0

69.6

775

3800

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

69.1

854

4343

Z51.0

ICD-10 Finland

Radiotherapy session

3.4

67.5

246

703

K83.0

ICD-10 Finland

Cholangitis

3.2

67.3

279

863

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

8.4

66.6

102

G04CB01

ATC

finasteride; oral

1.5

64.1

2649

18415

KDG43

NOMESCO Finland

Transobturatorial sling urethrocystopexy

8.7

62.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

62.2

9339

79897

XX1AD

NOMESCO Finland

Other CT-examination

4.4

60.5

155

345

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

59.2

392

1553

ZXA00

NOMESCO Finland

Right side

1.4

59.0

3397

25038

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

55.7

4538

35300

G03HA01

ATC

cyproterone; systemic

3.7

55.4

180

477

WVA20

NOMESCO Finland

Medicine administration

2.2

55.1

460

2018

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.8

54.8

126

257

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

54.6

7095

58925

WZC30

NOMESCO Finland

Teaching

1.4

54.4

2383

16696

L04AX01

ATC

azathioprine; systemic

2.1

53.7

529

2478

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.7

53.6

286

1019

WX002

NOMESCO Finland

Sedation and analgesia

1.4

53.6

2507

17774

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

9.7

53.3

WVA30, ,

SPAT

1.7

52.8

991

5719

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

52.5

614

3060

L02AE03

ATC

goserelin; implant

3.2

52.5

208

627

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

6.9

52.4

113

A28

ICPC

Limited function/disability NOS

1.4

51.4

2481

17674

G04BD12

ATC

mirabegron; oral

1.5

50.8

1692

11214

A07EA06

ATC

budesonide; oral, local oral

2.2

50.0

455

2067

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

49.9

1232

7630

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.3

49.8

386

1641

XKG00

NOMESCO Finland

Artificial induction of erection

5.9

49.7

148

Y85

ICPC

Benign prostatic hypertrophy

2.2

49.6

451

2047

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

7.9

48.5

A02BC02

ATC

pantoprazole; systemic

1.3

47.6

9175

79609

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

46.6

2468

17834

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.1

45.3

443

2068

A07EC02

ATC

mesalazine; oral, rectal

1.8

45.1

658

3525

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

45.1

3895

30346

L02BB05

ATC

apalutamide; oral

6.4

43.9

110

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

43.9

3636

28140

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

43.6

1186

7504

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.3

43.5

163

475

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

3.3

43.4

166

490

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

43.2

3453

26577

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

42.9

3665

28474

ZXD20

NOMESCO Finland

Day surgery

1.5

42.8

1403

9246

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

42.7

1945

13667

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

2.6

42.5

254

959

JN4AD

NOMESCO Finland

Body CT examination

1.4

42.4

1820

12650

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

42.4

1750

12075

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

42.4

4128

32645

N39.3

ICD-10 Finland

Stress incontinence

2.0

42.1

457

2219

3031

Kela drug reimbursment

Apalutamidi

6.3

41.2

108

WF049

NOMESCO Finland

Radiotherapy of metastasis

1.8

40.5

581

3096

L17

ICPC

Foot/toe symptom/complaint

1.3

40.2

3756

29491

1528, ,

Kela drug reimbursment

6.2

40.1

108

J01DB01

ATC

cefalexin; oral

1.3

39.8

11134

99964

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

39.7

296

1238

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

4.8

39.0

177

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

38.9

2847

21579

N30.0

ICD-10 Finland

Acute cystitis

1.5

38.8

1414

9515

R50.9

ICD-10 Finland

Fever, unspecified

1.4

38.2

1989

14283

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

3.7

38.0

119

308

Z01.7

ICD-10 Finland

Laboratory examination

1.4

37.8

1952

14001

A91

ICPC

Abnormal result investigation NOS

1.7

37.7

678

3863

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

37.7

9002

78933

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

37.6

1481

10114

KE2AT

NOMESCO Finland

Cytologoy of prostata with ultrasound guidance

10.7

37.2

XX7LT

NOMESCO Finland

Lutetium-177-PSMA treatment

9.9

37.0

U06

ICPC

Haematuria

1.9

36.7

466

2388

HB000

NOMESCO Finland

Profylactic radiotherapy of mammary gland

8.2

36.5

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

36.3

1819

12971

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

36.1

2383

17763

KE1CG, ,

SPAT

5.8

35.6

108

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

35.5

1626

11413

WVA20, ,

SPAT

1.9

35.4

479

2506

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

35.3

516

2765

R53

ICD-10 Finland

Malaise and fatigue

1.3

35.1

2839

21789

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

4.1

34.8

227

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.8

34.5

529

2878

N42.8

ICD-10 Finland

Other specified disorders of prostate

3.8

34.3

105

268

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.2

34.2

284

1245

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

34.0

2183

16191

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

33.8

484

2577

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

33.6

1061

6925

K51.5

ICD-10 Finland

Left sided colitis

2.1

33.6

336

1584

S18

ICPC

Laceration/cut

1.2

33.5

6506

55423

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

33.4

656

3825

JN2BM

NOMESCO Finland

Lower part of abdomen MRI examination with Tesla magnet

12.8

33.4

NK6AN

NOMESCO Finland

Total body bone isotope imaging

1.9

33.1

451

2366

U07

ICPC

Urine symptom/complaint other

1.5

33.1

1020

6625

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

32.7

1209

8145

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

32.7

2124

15771

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.7

32.5

175

628

A97

ICPC

No disease

1.3

31.6

2426

18449

A79

ICPC

Malignancy NOS

2.3

31.6

240

1014

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.1

31.5

304

1414

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

31.4

364

1810

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

31.4

1035

6816

WX892

NOMESCO Finland

Monitored bed care

1.5

31.0

1077

7165

L01BB02

ATC

mercaptopurine; oral

3.0

30.8

134

428

-1, ,

ICPC

1.8

30.8

444

2371

KE1JR

NOMESCO Finland

Extensive PET-CT of prostatic metabolism

11.0

30.5

U05

ICPC

Urination problems other

1.6

30.5

765

4744

KED22

NOMESCO Finland

Transurethral resection of prostate

1.5

30.5

1206

8231

K74.0

ICD-10 Finland

Hepatic fibrosis

5.6

30.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

29.8

1159

7881

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.6

29.8

174

651

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

29.5

1018

6761

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

7.0

29.5

B01AB10

ATC

tinzaparin; parenteral

1.4

29.5

1313

9155

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

29.3

2030

15196

C08CA01

ATC

amlodipine; oral

1.2

28.8

5486

46382

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

28.8

1260

8754

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

28.7

552

3201

L02BB06

ATC

darolutamide; oral

6.8

28.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

28.5

1312

9197

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.0

28.5

G04BD08

ATC

solifenacin; oral

1.6

28.4

776

4905

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

28.4

407

2170

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

4.4

28.2

153

OAB77

NOMESCO Finland

Discussion on exercise habits and instruction concerning use of sports and fitness services

7.9

28.1

R05

ICPC

Cough

1.3

28.1

2746

21526

A29

ICPC

General symptom/complaint other

1.4

28.1

1635

11919

K85

ICPC

Elevated blood pressure

1.3

28.0

2026

15253

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

5.7

28.0

WF004

NOMESCO Finland

Palliative radiotherapy

1.9

27.7

336

1697

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

27.6

2865

22619

KFC10

NOMESCO Finland

Bilateral orchiectomy

4.0

27.4

185

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

27.2

2994

23803

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

27.1

11713

107246

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

27.1

1244

8717

KE099

NOMESCO Finland

Other radiotherapy of prostata and seminal vesicles

9.7

27.0

ZXA10

NOMESCO Finland

Bilateral

1.3

26.6

2089

15899

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.0

26.5

289

1407

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1.9

26.5

331

1689

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.1

26.4

263

1240

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

3.6

26.1

236

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

4.3

26.0

147

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

25.9

709

4483

KE1DG, ,

SPAT

8.1

25.8

A01

ICPC

Pain general/multiple sites

1.4

25.6

1052

7221

U02

ICPC

Urinary frequency/urgency

1.4

25.5

1300

9268

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

25.5

2656

20958

ZX120

NOMESCO Finland

Intravenous

1.4

25.3

1105

7669

D16

ICPC

Rectal bleeding

1.9

25.3

305

1538

A02BC05

ATC

esomeprazole; systemic

1.2

25.2

4730

39787

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

2.2

25.2

219

980

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.2

25.1

218

974

H02AB06

ATC

prednisolone; systemic

1.2

25.1

6045

52063

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

25.1

2202

17000

J01CA04

ATC

amoxicillin; systemic

1.2

25.0

10333

93577

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

5.5

25.0

R44

ICPC

Respiratory, Preventive immunization/medic

2.2

24.7

198

857

M79.6

ICD-10 Finland

Pain in limb

1.2

24.6

4977

42140

K76.89

ICD-10 Finland

Other specified diseases of liver

5.3

24.5

S21

ICPC

Skin texture symptom/complaint

1.3

24.4

1842

13930

L03AA13

ATC

pegfilgrastim; parenteral

1.7

24.3

420

2367

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

24.1

5251

44749

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

24.0

1163

8219

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

23.9

371

2026

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

23.9

1035

7174

N03AX12

ATC

[U] gabapentin; oral

1.3

23.7

1752

13209

1525, ,

Kela drug reimbursment

6.7

23.4

3036, ,

Kela drug reimbursment

6.7

23.4

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

3.7

23.3

190

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

22.9

8605

76873

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

5.4

22.7

-1, ,

NOMESCO Finland

1.2

22.7

3400

27891

M54.5

ICD-10 Finland

Low back pain

1.2

22.6

3970

33095

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.7

22.3

119

427

N02BF01

ATC

gabapentin; oral

1.4

21.9

1113

7927

KEB00

NOMESCO Finland

Biopsy of prostate

2.0

21.9

243

1193

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

21.8

1173

8429

KMAK, ,

NOMESCO Finland

1.2

21.8

5530

47657

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

21.7

2527

20154

UJK02

NOMESCO Finland

ERCP

1.8

21.6

337

1845

SPAT1336

SPAT

Request for examination

1.7

21.6

380

2154

R74

ICPC

Upper respiratory infection acute

1.2

21.5

2797

22586

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.9

21.3

252

1265

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

21.1

151

623

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

21.1

621

3989

A07EA02

ATC

hydrocortisone; rectal

1.9

21.0

247

1237

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

9.0

20.8

A04

ICPC

Weakness/tiredness general

1.3

20.8

1661

12643

J01AA02

ATC

doxycycline; systemic

1.2

20.7

9872

89600

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

3.3

20.7

230

N06AX11

ATC

mirtazapine; oral

1.2

20.6

3681

30683

U01

ICPC

Dysuria/painful urination

1.6

20.5

547

3439

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

20.3

1500

11298

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

20.3

1503

11325

S29

ICPC

Skin symptom/complaint other

1.2

20.2

2399

19161

U77

ICPC

Malignant neopl urinary tract other

3.9

20.1

147

D01

ICPC

Abdominal pain/cramps general

1.4

20.0

1126

8149

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

6.8

19.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.7

19.8

388

2265

C10AA05

ATC

atorvastatin; oral

1.2

19.7

6156

53838

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

19.7

5212

44964

5BX04, ,

NOMESCO Finland

5.9

19.6

ZX112, ,

SPAT

2.9

19.5

304

R76.0

ICD-10 Finland

Raised antibody titre

22.5

19.5

D19

ICPC

Teeth/gum symptom/complaint

1.2

19.4

3156

26035

D97

ICPC

Liver disease NOS

3.2

19.4

239

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

5.0

19.4

JJA20

NOMESCO Finland

Open biopsy of liver

4.2

19.4

121

AA1AD

NOMESCO Finland

CT of head and brain

1.2

19.4

3896

32797

TQX20

NOMESCO Finland

Implantation of subcutaneous medicament implant

4.2

19.2

114

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

19.1

438

2660

Y50

ICPC

Male Genital, Medication/prescr/renewal

4.4

18.9

103

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

18.9

1541

11752

A02BC03

ATC

lansoprazole; oral

1.2

18.9

3227

26742

N06AX21

ATC

duloxetine; oral

1.4

18.8

1050

7587

XQ848

NOMESCO Finland

Dermatological photography

1.7

18.8

361

2097

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

18.7

407

2442

4194, ,

NOMESCO Finland

21.7

18.6

H02

ICPC

Hearing complaint

1.3

18.6

1925

15126

XX1XQ

NOMESCO Finland

Other SPECT-CT

4.6

18.5

R52.9

ICD-10 Finland

Pain, unspecified

1.4

18.5

1072

7789

JN1AE, ,

SPAT

1.8

18.4

297

1644

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

18.3

4487

38396

D06

ICPC

Abdominal pain localized other

1.4

18.2

814

5668

J01FA10

ATC

azithromycin; systemic

1.2

18.2

5893

51569

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.6

18.2

444

2738

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

3.7

18.1

145

OAB75

NOMESCO Finland

Nutritional guidance related to maintaining health

5.0

18.1

A03

ICPC

Fever

1.3

18.0

1642

12701

K92.1

ICD-10 Finland

Melaena

1.4

18.0

737

5056

D11

ICPC

Diarrhoea

1.4

17.9

1039

7553

R06AX27

ATC

desloratadine; oral

1.2

17.8

2456

19911

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.0

17.7

201

996

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.7

17.6

328

1889

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

17.6

787

5480

N41.0

ICD-10 Finland

Acute prostatitis

1.6

17.6

367

2177

L05

ICPC

Flank/axilla symptom/complaint

1.4

17.5

699

4770

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

17.5

593

3922

M79.7

ICD-10 Finland

Fibromyalgia

2.0

17.5

192

940

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

17.3

5305

46165

Y78

ICPC

Malign neopl male genital other

4.8

17.3

N48.4

ICD-10 Finland

Impotence of organic origin

1.6

17.3

447

2793

K22

ICPC

Risk factor cardiovascular disease

1.4

17.2

724

4989

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

3.2

17.2

197

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

17.1

448

2809

H02AB07

ATC

prednisone; oral

1.3

16.9

1421

10877

R42

ICD-10 Finland

Dizziness and giddiness

1.2

16.8

2601

21311

C10AA07

ATC

rosuvastatin; oral

1.2

16.8

4274

36621

A11

ICPC

Chest pain NOS

1.3

16.8

995

7253

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

16.7

6093

53696

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.5

16.7

478

3055

M01AH05

ATC

etoricoxib; oral

1.2

16.7

7251

64739

R03AC02

ATC

salbutamol; inhalant

1.2

16.7

6132

54072

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

16.6

422

2626

N06AX26

ATC

vortioxetine; oral

1.5

16.6

598

4004

R4190

NOMESCO Finland

Nutritional therapy

1.6

16.6

417

2589

R60.0

ICD-10 Finland

Localized oedema

1.3

16.5

1465

11288

U29

ICPC

Urinary symptom/complaint other

1.6

16.4

352

2105

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

16.3

667

4574

A02BC01

ATC

omeprazole; systemic

1.2

16.3

3085

25763

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

16.2

2384

19435

KE1AK

NOMESCO Finland

Spectroscopy of prostate

26.6

16.2

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

1.8

16.0

243

1323

J01MA06

ATC

norfloxacin; oral

1.3

16.0

1067

7917

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

15.9

1749

13817

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

15.9

4743

41119

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

15.9

4147

35574

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

15.9

3159

26486

H02AB02

ATC

dexamethasone; systemic

1.3

15.8

1219

9224

R01AD09

ATC

mometasone; nasal

1.2

15.8

4629

40072

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.5

15.8

490

3188

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

1.9

15.7

209

1092

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.6

15.6

372

2281

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

15.6

4732

41052

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

15.6

3777

32191

R51.80

ICD-10 Finland

Headache

1.3

15.5

1323

10138

A62

ICPC

General and Unspecified, Administrative procedure

1.7

15.5

261

1464

UJF92

NOMESCO Finland

Capsular endoscopy

1.8

15.5

225

1209

KE1AE

NOMESCO Finland

Percutaneous utlrasound examination fo prostata

2.6

15.5

333

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

15.5

727

5109

SFA10

NOMESCO Finland

One-surface restoration

1.2

15.4

6315

56007

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.5

15.3

459

2963

H25.8

ICD-10 Finland

Other senile cataract

0.7

15.3

815

10438

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.4

15.2

575

3887

R21

ICPC

Throat symptom/complaint

1.2

15.1

1667

13170

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

15.1

1030

7660

XQ855, ,

SPAT

2.0

15.0

154

737

R05

ICD-10 Finland

Cough

1.2

15.0

2300

18813

K51.8

ICD-10 Finland

Other ulcerative colitis

2.0

14.9

152

726

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.5

14.9

428

2739

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

14.9

1948

15682

D02

ICPC

Abdominal pain epigastric

1.5

14.8

536

3594

L57.0

ICD-10 Finland

Actinic keratosis

1.3

14.7

1345

10395

WYA20, ,

SPAT

2.3

14.7

105

435

K78

ICPC

Atrial fibrillation/flutter

1.3

14.7

1097

8264

R02

ICPC

Shortness of breath/dyspnoea

1.3

14.7

1550

12187

B82

ICPC

Anaemia other/unspecified

1.6

14.6

350

2150

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

14.6

3507

29837

SPAT1325

SPAT

Vaccination

1.2

14.6

4018

34564

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

14.4

2169

17701

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

14.3

7571

68210

130

Kela drug reimbursment

Malignant tumour

0.7

14.3

800

10181

XQ845

NOMESCO Finland

Dermatoscopy

1.7

14.3

247

1397

J01FA06

ATC

roxithromycin; oral

1.2

14.3

4220

36487

ZX114, ,

SPAT

2.0

14.3

162

805

P01AB01

ATC

metronidazole; oral, rectal

1.2

14.1

3952

34016

-50

ICPC

Medication/prescr/renewal

1.5

14.1

424

2740

D18

ICPC

Change in faeces/bowel movements

1.7

14.1

277

1621

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

14.1

675

4759

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

3.9

14.1

102

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.5

14.1

378

2385

K86

ICPC

Hypertension uncomplicated

1.2

14.1

1647

13096

ZXE00

NOMESCO Finland

One hour or less

1.2

14.0

4390

38104

L84

ICPC

Back syndrome without radiat pain

1.5

14.0

454

2982

N05CF02

ATC

zolpidem; oral

1.2

14.0

1570

12429

U08

ICPC

Urinary retention

1.6

13.9

362

2268

XQ858, ,

SPAT

2.4

13.9

363

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

3.8

13.9

103

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

13.9

1401

10955

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

13.9

830

6059

TQX05

NOMESCO Finland

Skin puncture, unspecified location

3.5

13.9

130

D07AC01

ATC

betamethasone; topical

1.2

13.8

4326

37549

F29

ICPC

Eye symptom/complaint other

1.3

13.8

1038

7829

L04AD01

ATC

ciclosporin; systemic

1.8

13.7

194

1035

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

13.7

733

5260

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.5

13.7

440

2883

R77.8

ICD-10 Finland

Other specified abnormalities of plasma proteins

10.5

13.6

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.4

13.6

522

3540

N41.1

ICD-10 Finland

Chronic prostatitis

1.5

13.6

418

2716

A60

ICPC

General and Unspecified, Result test/procedure

1.5

13.5

415

2695

R11

ICD-10 Finland

Nausea and vomiting

1.3

13.5

769

5573

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

13.5

446

2940

K86.2

ICD-10 Finland

Cyst of pancreas

2.0

13.4

134

636

K50.8

ICD-10 Finland

Other Crohn disease

2.0

13.4

138

663

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

13.3

1862

15083

K02.1

ICD-10 Finland

Caries of dentine

1.1

13.3

6813

61132

L03

ICPC

Low back symptom/complaint

1.2

13.3

2928

24714

L12

ICPC

Hand/finger symptom/complaint

1.2

13.3

1693

13583

R06AE07

ATC

cetirizine; oral

1.2

13.2

4251

36933

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.3

13.2

770

5603

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

13.1

3663

31498

H01

ICPC

Ear pain/earache

1.3

13.0

993

7501

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

5.5

13.0

R09

ICPC

Sinus symptom/complaint

1.4

12.9

553

3825

N30.4

ICD-10 Finland

Irradiation cystitis

3.4

12.9

132

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

12.9

1776

14362

S82

ICPC

Naevus/mole

1.2

12.8

1425

11264

R83

ICPC

Respiratory infection other

1.2

12.7

2046

16792

A27

ICPC

Fear of other disease NOS

1.4

12.7

505

3449

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.2

12.6

1466

11641

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

12.6

1919

15663

K83.1

ICD-10 Finland

Obstruction of bile duct

1.9

12.6

167

874

M79.1

ICD-10 Finland

Myalgia

1.3

12.6

1328

10433

X57

ICD-10 Finland

Unspecified privation

1.7

12.6

238

1382

R94.8

ICD-10 Finland

Abnormal results of function studies of other organs and systems

3.2

12.5

149

SFA20

NOMESCO Finland

Two-surface restoration

1.1

12.5

6648

59703

WX004

NOMESCO Finland

Patient-controlled sedation

2.7

12.4

238

N02AA05

ATC

oxycodone; systemic

1.2

12.4

2354

19599

A78

ICPC

Infectious disease other/NOS

1.9

12.4

162

844

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

12.4

1168

9057

TPH04, ,

SPAT

2.0

12.3

133

650

K30

ICD-10 Finland

Functional dyspepsia

1.3

12.3

1007

7677

GD1AA, ,

SPAT

1.2

12.3

1496

11941

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

12.3

568

3984

K96

ICPC

Haemorrhoids

1.6

12.3

262

1569

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

1.9

12.2

150

766

SPAT1342

SPAT

Referral to specialised care

2.0

12.2

120

567

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

2.3

12.2

386

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.3

12.2

362

G44.2

ICD-10 Finland

Tension-type headache

1.3

12.1

1056

8113

A23

ICPC

Risk factor NOS

1.3

12.0

852

6371

SPAT1301

SPAT

No procedures

1.2

12.0

3607

31149

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.4

11.9

448

3028

JAH01

NOMESCO Finland

Laparoscopy

1.5

11.9

357

2311

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

11.8

811

6038

H13

ICPC

Plugged feeling ear

1.2

11.8

2546

21432

-60

ICPC

Result test/procedure

1.4

11.7

552

3886

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

11.6

6351

57032

ZX198

NOMESCO Finland

Other local administration

2.0

11.6

115

546

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.7

11.5

322

4609

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.5

11.5

329

2107

A99

ICPC

Disease/condition unspecnature/site

1.3

11.5

1118

8704

SDA03

NOMESCO Finland

Periodontal treatment

1.1

11.4

4313

37813

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.2

11.3

1191

9353

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

11.3

2995

25603

L02

ICPC

Back symptom/complaint

1.3

11.3

837

6300

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

11.3

351

2289

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

11.3

791

5909

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.3

11.2

677

4950

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

11.2

1091

8491

C09CA06

ATC

candesartan; oral

1.2

11.2

2639

22356

K72.9

ICD-10 Finland

Hepatic failure, unspecified

2.4

11.2

286

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

13.1

11.2

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

2.0

11.2

125

620

R01AD58

ATC

fluticasone, combinations; nasal

1.2

11.2

2107

17527

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.1

11.1

4519

39796

C10AC01

ATC

colestyramine; oral

1.6

11.1

245

1480

KH1EE

NOMESCO Finland

Urologic ultrasound examination

2.8

11.0

182

H29

ICPC

Ear symptom/complaint other

1.2

11.0

1329

10597

N17

ICPC

Vertigo/dizziness

1.2

11.0

1265

10037

N42

ICD-10 Finland

Other disorders of prostate

3.2

10.9

122

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

10.9

2423

20431

L04

ICPC

Chest symptom/complaint

1.4

10.9

600

4331

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

10.8

275

1718

D07.5

ICD-10 Finland

Carcinoma in situ: Prostate

4.5

10.8

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

10.8

1071

8357

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

2.1

10.8

432

Z51.5

ICD-10 Finland

Palliative care

1.2

10.8

1165

9179

NXL00

NOMESCO Finland

Biopsy of muscle

2.8

10.7

174

N99.1

ICD-10 Finland

Postprocedural urethral stricture

2.1

10.7

452

UJH02

NOMESCO Finland

Anoscopy

1.5

10.7

371

2473

C10AA01

ATC

simvastatin; oral

1.1

10.6

5923

53145

E87.6

ICD-10 Finland

Hypokalaemia

1.5

10.6

334

2183

C07AB07

ATC

bisoprolol; oral

1.1

10.5

6667

60260

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

10.5

792

5975

L04AA06

ATC

mycophenolic acid; systemic

1.6

10.5

207

1217

D94

ICPC

Chronic enteritis/ulcerative colitis

2.4

10.5

295

K80

ICPC

Cardiac arrhythmia NOS

1.3

10.5

882

6749

R30.0

ICD-10 Finland

Dysuria

1.4

10.4

386

2605

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

4.8

10.4

WF099

NOMESCO Finland

Other radiotherapy

2.4

10.4

296

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

2.9

10.4

156

S04

ICPC

Lump/swelling localized

1.2

10.3

1075

8432

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

3.7

10.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

10.3

1062

8325

P06

ICPC

Sleep disturbance

1.2

10.3

1187

9419

A04AA01

ATC

ondansetron; systemic, rectal

1.3

10.2

793

6003

R5110, ,

SPAT

1.3

10.2

903

6949

B01AE07

ATC

dabigatran etexilate; oral

1.4

10.2

466

3264

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

1.7

10.2

176

1000

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

2.1

10.2

423

R77.0

ICD-10 Finland

Abnormality of albumin

15.4

10.1

J02AC01

ATC

fluconazole; systemic

1.2

10.1

2803

24025

N05CF01

ATC

zopiclone; oral

1.1

10.0

3512

30586

M48.0

ICD-10 Finland

Spinal stenosis

1.2

10.0

1473

11973

R96

ICPC

Asthma

1.3

10.0

916

7084

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.5

10.0

325

2142

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

1.8

9.9

143

771

ZXD00

NOMESCO Finland

Emergency procedure

0.6

9.9

146

2417

R06.0

ICD-10 Finland

Dyspnoea

1.1

9.9

3169

27431

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.4

9.9

399

2737

E0000UV, ,

ATC

1.1

9.9

4483

39689

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.5

9.8

315

2069

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

1.8

9.8

141

760

R4120

NOMESCO Finland

Occupational therapy

1.3

9.8

656

4872

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

9.8

315

2071

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.6

9.8

202

1203

H91.1

ICD-10 Finland

Presbycusis

1.3

9.7

778

5915

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

9.7

177

1021

EB1AA, ,

SPAT

1.3

9.7

555

4032

R03BA02

ATC

budesonide; inhalant

1.2

9.6

1643

13536

JGA28

NOMESCO Finland

Endoscopic contact coagulation in rectum

3.3

9.6

102

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

2.2

9.6

319

M03BX02

ATC

tizanidine; oral

1.1

9.6

6936

63030

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.2

9.6

1012

7950

C09CA01

ATC

losartan; oral

1.1

9.6

3172

27506

M01AE03

ATC

ketoprofen; systemic, rectal

1.1

9.6

4228

37346

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

1.5

9.6

249

1566

L04AA01

ATC

[U] ciclosporin

1.8

9.6

131

696

S08

ICPC

Skin colour change

1.3

9.5

563

4107

U28

ICPC

Limited function/disability (U)

1.8

9.5

133

711

U71

ICPC

Cystitis/urinary infection other

1.4

9.5

384

2635

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

9.5

417

2904

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.4

9.5

338

2268

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

9.4

167

956

J05AB01

ATC

aciclovir; systemic

1.2

9.4

2021

16976

1CD02, ,

NOMESCO Finland

2.4

9.4

244

L08

ICPC

Shoulder symptom/complaint

1.2

9.4

2524

21573

KE1DR

NOMESCO Finland

Prostate metabolic PET with CT

2.2

9.3

348

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

1.7

9.3

154

865

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

9.3

389

2687

T93

ICPC

Lipid disorder

1.3

9.3

761

5806

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

9.3

779

5961

WW500, ,

SPAT

4.4

9.2

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

1.8

9.2

131

704

B01AF02

ATC

apixaban; oral

1.2

9.2

1804

15038

SFA30

NOMESCO Finland

Three-surface restoration

1.1

9.2

4881

43569

P76

ICPC

Depressive disorder

1.4

9.2

427

3003

K63.5

ICD-10 Finland

Polyp of colon

1.5

9.2

277

1799

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

9.2

269

1737

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

2.5

9.2

201

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.2

9.1

1294

10479

Y99

ICPC

Genital disease male other

2.7

9.1

168

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

9.1

2169

18364

M25.5

ICD-10 Finland

Pain in joint

1.1

9.1

3188

27738

A61

ICPC

General and Unspecified, Result examination/test/record/letter from other provider

2.1

9.1

352

D64.8

ICD-10 Finland

Other specified anaemias

1.6

9.1

211

1294

ZYC01

NOMESCO Finland

Remote contact by phone

1.3

9.1

594

4399

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

9.1

2135

18063

N06AX16

ATC

venlafaxine; oral

1.2

9.0

1084

8636

K50.0

ICD-10 Finland

Crohn disease of small intestine

1.8

9.0

130

702

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

9.0

1878

15734

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

9.0

2145

18163

ZY010

NOMESCO Finland

Hospital outpatient

1.4

9.0

395

2753

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.9

9.0

105

531

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

9.0

600

4458

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.1

9.0

4691

41823

D12

ICPC

Constipation

1.4

8.9

403

2821

S15

ICPC

Foreign body in skin

1.3

8.9

705

5355

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.5

8.9

293

1938

K85.1

ICD-10 Finland

Biliary acute pancreatitis

2.0

8.8

427

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

11.0

8.8

ZX120, ,

SPAT

1.7

8.8

162

937

D09

ICPC

Nausea

1.5

8.8

295

1956

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.1

8.8

3856

34015

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

8.7

1703

14189

J05AB11

ATC

valaciclovir; oral

1.2

8.7

1333

10874

JAETT, ,

NOMESCO Finland

2.3

8.7

247

R00.2

ICD-10 Finland

Palpitations

1.3

8.7

582

4324

XA800

NOMESCO Finland

Neuropsychological investigation

1.4

8.7

433

3080

L95

ICPC

Osteoporosis

1.5

8.7

222

1392

OAB48

NOMESCO Finland

Lifestyle advice and guidance

2.5

8.7

195

Z2446

NOMESCO Finland

Social worker

1.3

8.7

570

4226

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

8.6

1110

8904

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

8.6

303

2028

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.3

8.6

819

6359

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

2.0

8.6

444

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

1.8

8.5

111

582

N06AB10

ATC

escitalopram; oral

1.2

8.5

1629

13555

253, ,

Kela drug reimbursment

2.9

8.5

126

3042, ,

Kela drug reimbursment

2.9

8.5

126

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.4

8.5

422

3002

S22

ICPC

Nail symptom/complaint

1.3

8.5

707

5408

SPAT1044

SPAT

Tympanometry

1.7

8.5

155

897

SF000, ,

NOMESCO Finland

3.0

8.4

116

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

3.2

8.4

101

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.0

8.4

448

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

8.4

2999

26107

XX7AT

NOMESCO Finland

Radiation therapy with Radium-223

4.2

8.4

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

4.2

8.4

B07.9

ICD-10 Finland

Verruca simplex

1.4

8.4

314

2129

8140/2-C61.9

ICD-O-3

Adenocarcinoma in situ, NOS, of prostate gland

11.1

8.4

N03AX16

ATC

[U] pregabalin

1.1

8.4

2398

20574

R04.0

ICD-10 Finland

Epistaxis

1.2

8.3

934

7387

ZX100

NOMESCO Finland

Oral

1.7

8.3

151

871

TJK01

NOMESCO Finland

Laparoscopic cholangiography

2.0

8.3

430

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.2

8.3

1091

8769

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

2.5

8.3

182

J01FA09

ATC

clarithromycin; systemic

1.1

8.3

2995

26090

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

8.3

8013

73700

WX110, ,

SPAT

1.3

8.3

460

3328

VALMI, ,

NOMESCO Finland

1.2

8.3

2163

18434

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

8.3

777

6027

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

8.3

1283

10480

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.2

8.3

916

7238

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

8.2

569

4247

K51

ICD-10 Finland

Ulcerative colitis

2.0

8.2

419

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

8.2

2641

22834

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

8.2

423

3027

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

7.1

8.2

K04

ICPC

Palpitations/awareness of heart

1.4

8.2

437

3144

F05

ICPC

Visual disturbance other

1.4

8.2

304

2058

A55

ICPC

General and Unspecified, Local injection/infiltration

1.8

8.2

124

681

CHD00

NOMESCO Finland

Laser trabeculoplasty

1.8

8.2

115

618

B80

ICPC

Iron deficiency anaemia

1.5

8.1

223

1421

U99

ICPC

Urinary disease other

1.9

8.1

475

D22

ICD-10 Finland

Melanocytic naevi

1.4

8.1

392

2778

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.0

8.0

403

R03DC03

ATC

montelukast; oral

1.2

8.0

1347

11087

R12

ICD-10 Finland

Heartburn

1.3

7.9

730

5649

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

32.2

7.9

XCK00

NOMESCO Finland

Perimetry

1.3

7.9

597

4510

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.2

7.9

808

6329

M02AA07

ATC

piroxicam; topical

1.1

7.9

3797

33636

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

7.9

560

4196

D02AX

ATC

Other emollients and protectives

1.5

7.9

224

1439

H02AB09

ATC

hydrocortisone; systemic

1.5

7.9

202

1269

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

7.9

1108

8969

P01BA02

ATC

hydroxychloroquine; oral

1.3

7.9

605

4582

L29

ICPC

Musculoskeletal sympt/complt other

1.2

7.9

826

6490

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.8

7.8

111

598

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.3

7.8

649

4961

OAA41

NOMESCO Finland

Health check based on individual needs

2.5

7.8

188

KDW96

NOMESCO Finland

Other operations on urethra

2.6

7.7

166

XF404

NOMESCO Finland

Ambulatory ECG

1.2

7.7

983

7880

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

2.5

7.7

172

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.1

7.7

2535

21944

UJK12

NOMESCO Finland

Peroral cholangioscopy

2.8

7.7

128

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

2.1

7.7

299

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

7.7

650

4982

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

7.7

285

1931

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

7.7

204

1293

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

1.5

7.6

212

1356

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.4

7.6

269

1805

M01AB05

ATC

diclofenac; systemic, rectal

1.1

7.6

7924

73002

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

7.6

137

790

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

3.6

7.6

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

1.6

7.6

169

1029

N30.8

ICD-10 Finland

Other cystitis

2.1

7.6

320

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

7.6

327

K80.8

ICD-10 Finland

Other cholelithiasis

1.7

7.6

140

814

L20

ICPC

Joint symptom/complaint NOS

1.4

7.5

302

2074

Y77

ICD-10 Finland

Ophthalmic devices associated with adverse incidents

14.5

7.5

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.1

7.5

3571

31596

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

7.5

477

3521

H40.0

ICD-10 Finland

Glaucoma suspect

1.2

7.5

780

6124

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.4

7.5

384

2748

D03

ICPC

Heartburn

1.4

7.5

297

2038

KE2KT

NOMESCO Finland

Marker implantation in prostate under radiological guidance

6.1

7.5

A38

ICPC

General and Unspecified, Other laboratory test NEC

1.9

7.5

441

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.2

7.4

731

5702

N06AX12

ATC

bupropion; oral

1.3

7.4

467

3445

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.1

7.4

2169

18627

ZX050

NOMESCO Finland

Stereotactic radiotherapy

1.8

7.4

103

553

298, ,

Kela drug reimbursment

3.4

7.4

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

7.4

956

7679

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

2.1

7.4

298

EBA00, ,

SPAT

1.5

7.4

231

1516

90621, ,

NOMESCO Finland

2.6

7.4

159

A02BA02

ATC

ranitidine; systemic

1.1

7.3

2004

17123

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

1.3

7.3

397

2864

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

1.8

7.3

101

540

B17.2

ICD-10 Finland

Acute hepatitis E

9.7

7.3

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

7.3

642

4942

F16

ICPC

Eyelid symptom/complaint

1.3

7.3

457

3368

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.3

7.3

472

3495

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.2

7.3

916

7334

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

1.6

7.3

170

1047

ZXD35

NOMESCO Finland

Usual procedure

1.4

7.3

312

2169

N28.1

ICD-10 Finland

Cyst of kidney

1.6

7.3

181

1131

S22.3

ICD-10 Finland

Fracture of rib

1.2

7.3

878

7002

Z50.1

ICD-10 Finland

Other physical therapy

1.3

7.3

496

3700

J01CA08

ATC

pivmecillinam; oral

1.2

7.3

1875

15960

B60

ICPC

Blood and Immunity, Result test/procedure

1.7

7.2

118

663

JN3AE, ,

SPAT

1.4

7.2

302

2090

N35.9

ICD-10 Finland

Urethral stricture, unspecified

1.5

7.2

183

1148

WZA90

NOMESCO Finland

Other medical or dental certificate

1.1

7.2

2348

20302

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.5

7.2

192

1218

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.2

7.2

238

256, ,

Kela drug reimbursment

3.2

7.2

E80.4

ICD-10 Finland

Gilbert syndrome

3.0

7.2

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.3

7.2

585

4466

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

1.6

7.2

149

893

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

7.2

688

5355

G04BE09

ATC

vardenafil; oral

2.6

7.1

150

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

1.6

7.1

154

931

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.2

7.1

753

5922

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.0

7.1

374

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

7.1

4962

44783

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.0

7.1

381

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.5

7.1

221

1449

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

1.6

7.1

142

843

SP000, ,

NOMESCO Finland

2.7

7.1

134

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

2.7

7.1

134

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.3

7.1

497

3722

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.1

7.1

2410

20897

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.1

332

2344

Z50.0

ICD-10 Finland

Cardiac rehabilitation

0.4

7.0

964

C10AX09

ATC

ezetimibe; oral

1.1

7.0

2233

19278

Y05

ICPC

Scrotum/testis sympt/compl other

1.6

7.0

162

996

A08

ICPC

Swelling

1.3

7.0

548

4162

F02

ICPC

Red eye

1.3

7.0

394

2861

R03BA01

ATC

beclometasone; inhalant

1.2

7.0

1257

10402

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

7.0

1136

9322

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.3

7.0

217

H26.4

ICD-10 Finland

After-cataract

1.2

6.9

980

7939

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.3

6.9

414

3033

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.2

6.9

917

7382

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.5

6.9

190

1214

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

3.1

6.9

SPAT1058

SPAT

PEF monitoring instruction

1.2

6.9

744

5866

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.3

6.9

364

2619

H04.10

ICD-10 Finland

Dry eye syndrome

1.2

6.9

961

7776

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.4

6.9

347

2479

U13

ICPC

Bladder symptom/complaint other

1.5

6.9

234

1562

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

0.5

6.8

1073

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

0.6

6.8

103

1686

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

1.4

6.8

242

1627

R01AD12

ATC

fluticasone furoate; nasal

1.1

6.8

2732

23922

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.4

6.8

269

1845

207

Kela drug reimbursment

Chronic arrhythmias

1.1

6.8

2182

18845

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

2.8

6.8

115

M34.1

ICD-10 Finland

CR(E)ST syndrome

3.0

6.8

WPA44, ,

SPAT

2.2

6.8

238

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.4

6.8

255

1734

WW502

NOMESCO Finland

Autotransfusion

1.8

6.8

456

NG2AA

NOMESCO Finland

Patella X-ray examination

0.6

6.7

110

1763

F38

ICPC

Eye, Other laboratory test NEC

1.6

6.7

152

930

HAMTE, ,

NOMESCO Finland

2.0

6.7

309

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.4

6.7

346

2480

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.4

6.7

233

1561

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

0.4

6.7

825

SPAT1255

SPAT

Intravenous administration of medicine

1.2

6.7

746

5903

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

6.7

306

2153

S85

ICPC

Pilonidal cyst/fistula

3.9

6.7

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.2

6.7

916

7400

C05AA08

ATC

fluocortolone; rectal, topical

1.2

6.7

1356

11334

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

1.9

6.7

383

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.1

6.7

2907

25576

JJC00

NOMESCO Finland

Allogenic transplantation of liver

2.8

6.7

111

R78.8

ICD-10 Finland

Finding of other specified substances, not normally found in blood

38.6

6.6

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

1.6

6.6

163

1017

SBA00

NOMESCO Finland

Microbiological examinations

1.5

6.6

206

1351

CBN99

NOMESCO Finland

Other operation on eyelid for malposition

1.9

6.6

378

P03

ICPC

Feeling depressed

1.3

6.6

614

4764

N30.9

ICD-10 Finland

Cystitis, unspecified

1.3

6.6

461

3453

R03AK07

ATC

formoterol and budesonide; inhalant

1.1

6.6

1995

17165

Z71.9

ICD-10 Finland

Counselling, unspecified

1.2

6.6

738

5846

XF640, ,

NOMESCO Finland

0.6

6.5

144

2153

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.0

6.5

352

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

6.5

253

1730

WX320

NOMESCO Finland

Spinalanesthesy

1.1

6.5

2835

24935

KGB00

NOMESCO Finland

Biopsy of penis

2.6

6.5

140

3029

Kela drug reimbursment

Upadacitinib

3.2

6.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.1

6.5

2334

20295

J01DA06

ATC

[U] cefuroxime

1.2

6.5

1269

10575

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.2

6.5

782

6240

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.2

6.5

698

5505

I49.5

ICD-10 Finland

Sick sinus syndrome

1.3

6.5

395

2905

SPAT1215

SPAT

Assessment of need for medical rehabilitation

0.7

6.5

186

2632

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

6.5

334

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

1.6

6.4

135

812

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

2.1

6.4

256

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.4

6.4

278

1938

Z94.4

ICD-10 Finland

Liver transplant status

2.4

6.4

170

R41.3

ICD-10 Finland

Other amnesia

1.4

6.4

300

2119

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

2.6

6.4

130

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.4

6.4

279

1950

A10BB01

ATC

glibenclamide; oral

0.7

6.3

240

3234

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

1.6

6.3

147

906

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

1.6

6.3

134

808

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

0.2

6.3

273

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.4

6.3

241

1645

RD211, ,

NOMESCO Finland

1.3

6.3

383

2815

-62

ICPC

Administrative procedure

1.4

6.3

235

1597

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

1.8

6.3

474

Y26

ICPC

Fear of genital cancer male

3.4

6.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.1

6.3

3279

29123

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

6.3

216

1446

R55

ICD-10 Finland

Syncope and collapse

1.2

6.3

1292

10810

S19

ICPC

Skin injury other

1.3

6.3

399

2952

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.2

6.3

742

5910

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.3

6.3

578

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.4

6.3

222

1495

WZA00

NOMESCO Finland

Concise certificate

1.3

6.2

528

4054

B01AB04

ATC

dalteparin; parenteral

1.3

6.2

486

3694

F92

ICPC

Cataract

1.9

6.2

359

SBA10

NOMESCO Finland

Measurement of salivary flow rate

1.9

6.2

407

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

2.0

6.2

319

Z31.5

ICD-10 Finland

Genetic counselling

1.4

6.2

306

2182

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

6.2

420

3137

UKD02

NOMESCO Finland

Urethroscopy

1.9

6.2

360

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.3

6.1

320

2300

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

1.4

6.1

217

1461

K76

ICD-10 Finland

Other diseases of liver

6.3

6.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.3

6.1

358

2617

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.4

6.1

285

2013

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

1.7

6.1

109

630

KE003

NOMESCO Finland

Adjuvant radiotherapy of prostata and seminal vesicles

5.0

6.1

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.1

280

1974

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1.9

6.1

328

ZX136

NOMESCO Finland

Intravesicalis

1.8

6.1

487

S50

ICPC

Skin, Medication/prescr/renewal

1.9

6.1

362

I25.2

ICD-10 Finland

Old myocardial infarction

0.8

6.1

664

7775

KED76

NOMESCO Finland

TUVP

0.4

6.1

681

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.3

6.0

372

2740

K43

ICPC

Cardiovascular, Other diagnostic procedure

1.7

6.0

559

-38

ICPC

Other laboratory test NEC

2.0

6.0

322

T69

ICPC

Metabolic, Other reason for encounter NEC

2.0

6.0

289

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.0

3636

32532

R07.0

ICD-10 Finland

Pain in throat

1.3

6.0

529

4081

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037467) Urinalysis macro (dipstick) panel - Urine

11119

84309

2.12

320.14

5.2

4.5

2.47

2.35

0.07

127

(3026782) Osmolality of Urine

4705

26717

2.03

313.90

3.5

3.1

578.02

558.54

mosm/kgh2o

1.43

4301

23597

(3016650) Hepatitis A virus Ab [Presence] in Serum

815

1868

4.40

307.78

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1945

3039

6.96

307.65

1.4

1.2

128.02

102.83

titre

0.80

253

258

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3855

16376

2.72

307.65

2.3

10.25

13.68

nmol/l

90.93

3357

14649

(3034770) Mitochondria Ab [Titer] in Serum

1917

2986

6.97

307.65

1.4

1.2

862.18

1102.59

titre

0.60

(3037522) Nuclear Ab [Titer] in Serum

3150

15127

2.28

307.65

1.6

1.3

540.13

457.29

titre

1.70

757

3075

(3024561) Albumin [Mass/volume] in Serum or Plasma

8943

59475

2.15

307.65

6.7

5.6

35.37

34.99

g/l

8.07

8589

55804

(3028026) IgM [Mass/volume] in Serum or Plasma

2373

7233

3.58

307.65

1.9

1.31

1.27

g/l

0.34

2249

6611

(40768800) Prostate Pathology biopsy report

3341

3549

11.46

307.65

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2647

9334

3.12

307.65

2.9

2.7

10.76

10.74

g/l

0.08

2533

8608

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9857

63581

2.51

307.65

8.7

4.3

17.22

23.01

307.65

7261

31953

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9773

68914

2.10

307.65

8.9

7.2

12.94

12.81

umol/l

0.35

9548

65920

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

12174

94748

2.40

307.65

31.3

23.8

333.10

333.18

g/l

0.47

12120

94200

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4922

24047

2.47

307.65

3.7

3.2

0.88

0.99

e6/l

0.46

2752

13401

(3031040) Bacteria [#/volume] in Urine by Automated count

11682

79915

3.00

307.65

5.7

4.6

383.65

976.67

e6/l

1.98

304

1230

(3026008) Bacteria identified in Urine by Culture

5761

33736

2.06

307.65

3.6

3.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12237

95167

2.44

307.65

29.3

22.7

13.83

13.77

4.96

12170

93872

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6807

41861

2.06

307.65

4.9

3.3

42.58

36.04

u/l

6.12

6557

39325

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7359

46942

2.03

307.65

4.7

3.2

1.13

0.74

ug/l

62.70

6048

32183

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12853

96293

3.30

307.65

12.1

8.8

90.20

80.63

u/l

37.49

12620

91465

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

931

1701

5.57

307.65

1.1

1.48

1.55

g/l

5.48

876

1543

(3006922) Hepatitis E virus Ab [Presence] in Serum

641

837

7.68

307.65

1.1

—

(36304419) Bacteria [Presence] in Urine

6665

36187

2.42

307.65

4.1

3.5

3.27

434.16

estimate

0.81

172

(3000850) Epithelial cells [#/volume] in Urine

5623

31747

2.15

307.65

3.1

2.9

2.93

3.59

e6/l

7.62

5249

29029

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10907

80305

2.20

307.65

11.4

5.4

6.72

3.04

ug/l

16.69

10211

72365

(3002582) Erythrocytes [#/volume] in Urine

7982

45026

2.55

307.65

4.5

3.6

60.12

118.31

e6/l

3.04

6456

35146

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

680

865

7.90

307.65

1.1

293.85

279.95

mg/l

3.44

645

781

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

851

1742

4.94

307.65

1.4

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

6885

38853

2.34

307.65

4.2

3.5

0.26

0.47

e6/l

20.54

5363

29220

(3018095) Leukocytes [#/volume] in Urine

8290

49128

2.44

307.65

5.2

4.2

59.48

101.37

e6/l

4.26

6572

36277

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4642

22108

2.50

307.65

4.0

3.4

1.16

1.22

e6/l

0.26

2461

11399

(3017143) Hepatitis C virus Ab [Presence] in Serum

2598

12092

2.30

285.84

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

5470

33607

1.91

283.30

5.4

4.6

86.17

83.63

11.36

5386

32959

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

809

1964

4.15

282.96

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3008

15056

2.17

275.97

3.4

3.0

9.85

10.26

umol/l

0.36

2757

13434

(3044889) 12 lead EKG panel

11129

86849

1.97

260.05

4.8

4.6

0.56

3602.72

1.18

212

(3013650) Neutrophils [#/volume] in Blood by Automated count

9568

71349

1.84

254.36

11.1

9.8

4.29

4.35

e9/l

1.29

8219

61640

(40758558) Short blood count panel - Blood

5720

37137

1.80

236.88

7.0

6.8

—

(3035350) Ketones [Presence] in Urine by Test strip

8894

65615

1.78

236.39

4.5

3.8

3.24

4.42

estimate

0.30

1586

14403

(3018418) pH of Serum or Plasma

5877

38548

1.78

234.40

5.3

4.7

7.40

0.52

4285

27872

(3009261) Glucose [Presence] in Urine by Test strip

8913

65923

1.77

233.41

4.5

3.8

0.02

0.36

estimate

1.59

1493

13213

(3021601) Nitrite [Presence] in Urine by Test strip

8798

64863

1.77

232.62

4.4

3.8

0.00

estimate

0.40

1571

14202

(3014051) Protein [Presence] in Urine by Test strip

5160

32727

1.80

229.30

3.2

2.9

0.11

0.07

0.44

102

865

(3019150) Specific gravity of Urine by Refractometry

4587

28229

1.82

224.16

4.9

4.0

1.02

1.13

kg/l

0.81

3459

19006

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2765

14452

2.04

220.77

1.7

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3624

20886

1.89

217.06

1.8

1.5

2.57

2.69

g/l

2.63

2679

12801

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3739

21901

1.87

212.14

2.7

2.9

24.01

22.94

4.78

3607

20310

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3939

23551

1.84

208.72

2.7

2.8

2.30

2.25

g/l

6.44

3765

21721

(3022948) Iron [Moles/volume] in Serum or Plasma

4110

24957

1.82

206.65

2.8

18.43

12.82

umol/l

0.61

3956

23209

(3015736) pH of Urine

7306

52181

1.70

205.81

4.1

3.4

6.23

6.18

3.57

4284

28678

(3011397) Hemoglobin [Presence] in Urine by Test strip

4688

29650

1.77

205.08

4.1

3.6

0.32

0.18

0.58

300

(3019550) Sodium [Moles/volume] in Serum or Plasma

13948

122001

3.04

200.77

26.9

22.8

139.60

139.64

mmol/l

1.34

13840

119745

(3023103) Potassium [Moles/volume] in Serum or Plasma

13962

122221

3.06

200.01

27.2

23.0

4.00

4.02

mmol/l

18.30

13847

119796

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13591

117592

2.54

195.71

22.7

18.7

29.25

28.20

mg/l

2.89

11924

99392

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2579

13686

1.99

194.83

2.8

2.4

0.21

0.20

g/l

10.59

2433

12717

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8758

66311

1.68

191.81

9.4

8.1

1.20

mmol/l

0.22

8034

57038

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8077

59987

1.66

189.57

3.2

3.0

—

estimate

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8033

59616

1.66

188.71

8.3

7.5

1.20

mmol/l

2.51

7708

55136

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

505

1173

4.26

186.50

1.3

1.2

57.76

68.19

u/l

1.39

459

1016

(40768441) Liver Pathology biopsy report

442

925

4.72

186.13

1.3

1.4

—

(3032080) INR in Blood by Coagulation assay

8845

67624

1.66

181.80

17.9

18.4

1.30

1.33

inr

6.74

7376

57316

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2311

12181

1.98

176.37

3.1

2.6

0.30

0.44

e6/l

3.90

2241

11777

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14107

125241

3.19

175.53

30.8

24.8

86.66

86.76

umol/l

0.10

14035

123791

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13966

123811

2.79

164.72

16.8

13.0

31.80

27.49

u/l

38.87

13799

119924

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7344

54514

1.60

161.88

3.5

3.1

184.14

168.44

ug/l

2.41

6997

50349

(3001604) Monocytes [#/volume] in Blood

8417

64804

1.59

156.64

7.4

6.3

0.62

0.63

e9/l

5.23

7096

55283

(3006315) Basophils [#/volume] in Blood

8435

65047

1.59

155.26

7.5

6.3

0.04

e9/l

0.39

7119

55514

(3013115) Eosinophils [#/volume] in Blood

8614

66775

1.59

154.87

7.7

6.5

0.20

e9/l

0.03

7415

57845

(3019198) Lymphocytes [#/volume] in Blood

8547

66152

1.59

154.54

7.5

6.4

1.81

1.89

e9/l

2.87

7386

57800

(3024980) IgG subclass 4 [Mass/volume] in Serum

642

2010

3.18

152.20

1.7

0.79

0.89

g/l

1.65

533

1574

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2645

15337

1.81

147.84

8.5

9.4

121.57

122.61

g/l

1.71

2564

15027

(3007461) Platelets [#/volume] in Blood

14126

126718

2.97

147.82

35.3

28.1

236.40

236.04

e9/l

0.27

13941

123905

(3035941) MCH [Entitic mass]

14127

126742

2.97

147.59

35.1

27.9

30.54

30.56

0.93

14072

125260

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

14127

126752

2.96

147.37

36.1

28.7

40.30

40.87

8.57

14067

125223

(3024731) MCV [Entitic mean volume] in Red Blood Cells

14127

126753

2.96

147.35

35.1

28.0

91.53

91.61

1.21

14073

125271

(3026361) Erythrocytes [#/volume] in Blood

14127

126759

2.96

147.21

35.2

28.0

4.48

4.51

e12/l

8.91

13890

123458

(3000963) Hemoglobin [Mass/volume] in Blood

14128

126778

2.96

147.09

35.5

28.2

135.27

136.84

g/l

25.87

14082

125315

(3010813) Leukocytes [#/volume] in Blood

14126

126769

2.96

146.69

35.2

28.1

6.86

6.95

e9/l

4.90

13900

123473

(3013826) Glucose [Moles/volume] in Serum or Plasma

9840

79273

1.60

145.10

6.5

5.7

6.84

6.89

mmol/l

1.37

9426

75891

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10850

89732

1.64

141.14

5.2

4.4

13.50

12.33

mm/h

10.92

10409

83483

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1766

9145

1.98

139.37

9.7

11.1

16.27

16.18

0.69

1689

8867

(3019977) pH of Arterial blood

3022

18502

1.72

138.86

8.1

8.5

7.41

7.42

0.35

1617

10151

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3021

18521

1.72

138.02

8.1

8.5

5.04

5.07

kpa

1.26

2899

17839

(3027801) Oxygen [Partial pressure] in Arterial blood

3018

18511

1.72

137.61

8.0

8.5

12.40

12.05

kpa

3.08

2897

17820

(3015377) Calcium [Moles/volume] in Serum or Plasma

5838

42233

1.55

135.42

4.3

3.6

2.35

2.34

mmol/l

1.53

5445

38259

(3003396) Base excess in Arterial blood by calculation

2991

18404

1.71

134.38

8.0

8.4

0.69

0.84

mmol/l

1.35

2459

15197

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

386

946

4.02

132.47

1.3

1.2

84.29

151.61

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

386

946

4.02

132.47

1.3

1.2

201.64

139.47

titre

0.63

170

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

679

2374

2.84

132.27

1.2

1.3

26.87

57.95

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4043

27037

1.61

130.70

4.4

4.3

628.05

620.53

ng/l

0.01

3489

22796

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

306

637

4.71

129.56

1.2

1.1

94.39

89.03

u/l

0.42

292

561

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6532

48746

1.53

129.48

4.6

3.8

0.10

0.22

estimate

0.54

1270

11847

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

641

2202

2.89

128.95

1.3

273.86

265.63

u/ml

0.27

392

1381

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

304

632

4.72

128.92

1.2

1.1

25.65

28.75

u/l

0.34

288

551

(3018010) Neutrophils/Leukocytes in Blood

7731

59867

1.52

128.23

7.6

6.4

58.58

58.45

0.43

7497

57127

(3016502) Oxygen saturation in Arterial blood

2759

16795

1.72

128.17

8.2

8.8

95.94

95.35

5.78

2635

16285

(3002030) Lymphocytes/Leukocytes in Blood

7843

61142

1.51

124.32

7.7

6.6

25.92

26.09

0.67

7547

57870

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3520

23062

1.62

122.38

1.4

1.3

1.54

1.98

u/ml

1.45

906

5950

(3019069) Monocytes/Leukocytes in Blood

7708

60035

1.50

121.52

7.8

6.7

9.17

9.21

0.47

7377

56203

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2103

12071

1.79

119.15

3.0

2.6

54.63

48.89

u/l

0.13

1833

10262

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1131

5264

2.16

118.22

1.5

1.7

0.27

0.33

mg/l

2.24

483

2705

(3006504) Eosinophils/Leukocytes in Blood

7664

59871

1.49

117.27

7.7

6.6

2.94

2.88

1.09

7343

56026

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13324

118233

1.94

115.47

6.6

6.2

2.53

2.52

mmol/l

0.61

12825

109350

(3022096) Basophils/Leukocytes in Blood

7653

59918

1.48

114.74

7.8

6.7

0.67

0.65

2.09

7326

56087

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

294

654

4.40

114.64

1.5

1.6

9.40

6.91

u/l

1.19

232

513

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

670

2555

2.60

109.99

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2735

17226

1.65

109.68

2.0

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4973

35923

1.51

109.50

2.5

2.4

2.66

2.88

mg/l

9.33

4459

30778

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12855

113156

1.77

109.47

7.2

39.72

40.23

mmol/mol

8.40

12390

105128

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5668

42332

1.47

104.40

3.5

2.8

60.36

67.94

u/l

1.72

5389

39347

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12954

114646

1.76

103.16

5.7

5.6

6.08

6.12

mmol/l

2.95

12362

104539

(3023368) Bacteria identified in Blood by Culture

5667

42451

1.47

102.12

4.9

4.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

762

3196

2.37

101.87

1.3

—

(3000991) Gas panel - Venous blood

2215

13450

1.69

101.36

9.6

10.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

649

2541

2.53

100.79

1.4

1.5

20.33

18.05

u/ml

0.20

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

278

661

4.12

99.37

1.3

118.15

101.61

u/l

1.26

241

546

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

342

956

3.51

96.98

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13060

116272

1.75

96.07

5.6

5.5

4.38

4.35

mmol/l

3.81

12614

107950

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7464

59353

1.43

95.37

2.3

2.2

92.13

93.13

pmol/l

1.23

4286

34124

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6592

51333

1.43

93.99

2.7

2.3

77.58

76.50

nmol/l

2.41

6149

45759

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

709

2993

2.35

93.28

5.1

6.0

2022.40

1131.55

iu/ml

0.23

483

(3048689) Calprotectin [Mass/mass] in Stool

2120

13018

1.67

92.20

3.0

2.5

154.32

158.30

ug/g

0.18

1810

10395

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

586

2280

2.54

92.12

1.4

1.5

153.42

152.32

au/ml

0.07

143

723

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3358

23006

1.53

91.75

2.2

2.1

29.69

30.09

3.44

3260

22422

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

263

646

3.98

89.96

1.3

33.15

28.01

u/l

0.65

226

528

(3039000) Anion gap in Blood by calculation

710

3069

2.29

88.36

6.3

7.7

11.20

11.37

mmol/l

0.67

636

2791

(3018572) Chloride [Moles/volume] in Blood

710

3070

2.29

88.29

6.3

7.7

104.93

105.13

mmol/l

0.54

636

2792

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

933

16770

0.51

87.87

5.3

31.75

32.01

0.30

673

11288

(3014111) Lactate [Moles/volume] in Serum or Plasma

2240

14107

1.63

87.77

8.2

8.4

1.35

1.39

mmol/l

0.78

2207

13787

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1665

9708

1.74

87.39

7.0

7.6

24.36

24.39

mmol/l

0.12

1574

9333

(3047181) Lactate [Moles/volume] in Blood

926

4472

2.06

87.11

5.8

6.5

1.30

1.36

mmol/l

1.01

803

3979

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12941

115484

1.68

86.90

5.4

1.37

1.35

mmol/l

5.52

12415

106423

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

748

3395

2.19

82.61

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2769

18580

1.54

81.98

2.0

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12104

106640

1.54

81.87

5.0

4.7

2.01

2.00

mu/l

0.15

11438

97128

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

606

2540

2.36

80.91

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3508

24788

1.48

80.83

3.3

2.46

2.45

mmol/l

3.02

3145

22188

(3007930) Methemoglobin/Hemoglobin.total in Blood

1174

6356

1.85

78.73

5.7

5.6

0.90

0.87

2.85

1104

6029

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1428

8207

1.75

78.40

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

157

286

5.34

77.60

1.2

17.31

15.66

umol/l

2.87

143

253

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1890

11747

1.63

77.27

3.1

203.08

234.15

ng/l

2.11

1738

10832

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

568

2366

2.37

76.88

2.7

3.0

3114.31

5844.30

u/ml

0.29

152

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9402

79364

1.40

76.54

5.0

3.5

80.84

56.58

u/l

48.98

9009

73964

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1251

6979

1.80

75.95

5.5

5.4

1.69

1.62

1.79

1177

6640

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1004

5243

1.91

75.23

3.8

3.7

956.18

1613.74

u/ml

0.52

876

4602

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

12743

114182

1.58

73.12

22.3

18.6

77.60

77.61

ml/min/173m2

0.02

12079

106490

(3021589) Normoblasts [#/volume] in Blood

6919

55841

1.37

72.45

13.2

12.7

0.00

e9/l

0.53

5389

45780

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2357

15743

1.53

70.01

4.8

4.2

5.76

5.80

kpa

1.04

2308

15381

(3012544) pH of Venous blood

2393

16066

1.52

69.32

4.9

4.2

7.38

0.36

1376

9582

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

417

1583

2.59

68.89

2.7

3.8

4.28

12.31

nmol/l

1.51

407

1546

(3021960) Folate [Moles/volume] in Serum or Plasma

5052

39227

1.37

65.32

1.9

1.7

19.03

19.22

nmol/l

0.46

4623

33156

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1687

10625

1.60

64.51

9.8

10.6

1.22

1.32

4.91

1679

10555

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1641

10271

1.61

64.40

10.1

10.9

0.58

0.62

5.11

1632

10210

(3002032) Base excess in Venous blood by calculation

2279

15366

1.51

64.19

4.8

4.2

1.52

1.62

mmol/l

0.67

2026

13376

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

928

4981

1.85

63.57

1.2

1.1

35.43

12.88

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2138

14285

1.52

62.74

1.9

1.8

1.59

1.58

0.11

1861

12253

(36660697) Celiac disease serology panel - Serum

1343

8068

1.67

61.96

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4434

34006

1.37

60.88

3.8

3.3

0.23

0.20

estimate

0.05

1210

11039

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

956

5273

1.80

59.83

1.8

42.35

38.19

u/l

6.29

851

4593

(40768804) Tissue Pathology biopsy report

5929

47764

1.33

57.97

2.4

2.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2631

18587

1.45

57.83

4.7

4.6

252.90

244.40

u/l

1.29

2546

17658

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1440

8971

1.61

57.23

4.7

4.4

24.00

23.98

mmol/l

0.07

1429

8853

(3027945) Reticulocytes/Erythrocytes in Blood

2613

18567

1.43

55.37

2.8

2.6

1.76

1.74

0.49

2443

16465

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1308

8045

1.62

54.67

3.2

3.1

1.21

1.23

0.24

1301

8009

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1036

6002

1.72

54.50

1.5

6.36

16.53

iu/ml

3.78

128

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6180

50414

1.31

53.96

2.0

1.33

1.35

mmol/l

0.62

5597

41319

(3003694) ABO and Rh group [Type] in Blood

4483

35052

1.34

52.34

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12306

111033

1.43

52.01

4.6

1.31

mmol/l

0.06

11686

101387

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9827

85713

1.32

51.11

4.0

3.8

14.86

14.88

pmol/l

0.51

9245

77480

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1525

9874

1.55

50.98

10.0

10.3

23.95

24.17

mmol/l

2.14

1507

9632

(3024354) Oxygen [Partial pressure] in Venous blood

1915

13045

1.48

50.18

3.9

3.4

4.48

4.55

kpa

0.70

1868

12699

(3015171) Extractable nuclear Ab [Units/volume] in Serum

701

3760

1.84

47.90

1.3

1.2

0.90

0.73

u/ml

0.18

318

(3049717) Cytology report of Urine Cyto stain

1187

7371

1.60

47.43

2.7

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2368

16977

1.41

46.84

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1478

9673

1.53

46.82

4.1

3.5

126.83

130.26

g/l

6.38

1444

9399

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7527

63743

1.29

46.77

2.7

2.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1631

10940

1.49

45.88

3.2

2.9

65.88

63.26

ml/min/173m2

1.80

689

4676

(3024139) IgG subclass 3 [Mass/volume] in Serum

309

1236

2.44

45.77

1.5

1.4

0.41

0.44

g/l

0.56

234

900

(3028192) IgG subclass 2 [Mass/volume] in Serum

309

1237

2.44

45.69

1.6

1.4

3.11

3.02

g/l

0.36

234

903

(3027135) IgG subclass 1 [Mass/volume] in Serum

309

1238

2.44

45.61

1.6

1.4

7.11

6.87

g/l

0.45

233

902

(3019225) pH of Specimen

862

13366

0.60

45.58

4.4

7.33

7.36

2.21

664

9844

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

870

5058

1.70

44.98

1.4

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1495

9920

1.51

44.23

1.8

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2683

19854

1.37

43.54

7.2

6.8

1.04

1.03

mmol/l

1.10

2556

18673

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

787

4492

1.73

43.49

2.1

2.4

0.03

g/l

0.16

719

4048

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

720

4040

1.76

42.25

2.2

2.5

0.00

g/l

-0.00

670

3803

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

757

4311

1.73

42.16

2.2

2.5

0.00

g/l

0.97

671

3811

(4062490) Immunoglobulin typing, IgG

297

1213

2.39

42.05

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1419

9452

1.50

41.05

4.8

4.7

94.87

101.99

ng/l

1.95

1300

8178

(3034274) Bile acid [Moles/volume] in Serum --fasting

208

724

2.80

40.86

3.4

2.1

12.40

11.77

umol/l

0.10

176

526

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

885

5310

1.65

40.49

2.2

2.4

10.24

g/l

0.01

813

4740

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

432

2084

2.03

40.48

2.7

2.9

1291.36

808.29

u/ml

0.26

425

2053

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1179

7572

1.55

40.47

1.7

1.51

1.53

g/l

0.33

1041

6492

(3020630) Protein [Mass/volume] in Serum or Plasma

1823

12798

1.43

40.05

2.5

2.7

65.87

66.15

g/l

0.81

1700

11800

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

122

320

3.70

38.25

2.4

2.5

218.64

513.40

ug/l

0.60

122

320

(3039162) Centromere protein B Ab [Units/volume] in Serum

286

1200

2.32

38.12

1.3

1.2

62.11

44.21

u/ml

0.47

(3029937) Albumin [Presence] in Urine by Test strip

4634

37601

1.28

37.94

4.9

3.9

0.00

estimate

1.44

1386

12542

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

696

4002

1.71

37.39

1.6

1.4

7.77

12.95

iu/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

762

4507

1.67

36.81

1.9

1.6

7.01

7.08

iu/ml

0.02

174

1047

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3238

25169

1.31

36.75

2.1

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

985

6235

1.56

35.96

2.2

2.4

3.81

3.74

g/l

0.61

923

5716

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

169

565

2.91

35.81

1.3

1.4

1572101.50

1335395.11

iu/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

987

6257

1.56

35.79

2.2

2.4

7.32

7.28

g/l

0.35

922

5734

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

986

6252

1.56

35.72

2.2

2.4

4.19

4.16

g/l

0.43

924

5739

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1579

11022

1.43

35.53

2.4

2.6

387.95

376.44

nmol/l

1.02

1509

10277

(3024928) Oxygen saturation in Venous blood

666

3844

1.70

35.27

3.5

3.4

60.26

62.00

1.13

647

3693

(3026493) Urate [Moles/volume] in Serum or Plasma

4651

38026

1.26

35.05

3.3

3.1

364.70

365.49

umol/l

0.20

4188

33328

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5191

43060

1.25

34.31

2.5

2.3

275.17

237.75

u/l

0.89

4972

40757

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

226

898

2.45

34.07

1.2

82.44

83.73

0.10

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

928

5870

1.56

33.95

2.2

2.4

2.97

2.87

g/l

2.38

863

5354

(3023183) Ammonium ion [Moles/volume] in Plasma

638

3683

1.70

33.76

2.8

2.7

31.82

33.80

umol/l

1.52

587

3296

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

407

2061

1.93

33.23

1.3

1.2

55.43

36.43

u/ml

0.84

169

(3052851) Hemolysis interference index of Serum or Plasma

632

3661

1.70

33.02

3.6

3.7

2.39

2.14

index

0.26

336

1937

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

856

5357

1.57

32.79

2.3

2.5

0.84

0.88

g/l

0.14

770

4609

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3060

24109

1.28

30.43

3.7

0.81

mmol/l

0.01

2913

22749

(3020779) Urea [Moles/volume] in Serum or Plasma

2048

15322

1.34

29.74

8.2

7.8

10.66

10.83

mmol/l

0.47

1978

14620

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1994

14870

1.34

29.58

4.0

4.6

19.41

30.84

ug/l

1.28

1644

12517

(3042936) Bacteria identified in Isolate by Culture

2683

20878

1.29

29.24

2.3

2.2

—

(3023520) Reticulocytes [#/volume] in Blood

1958

14655

1.33

28.23

2.6

2.7

68.47

68.15

e9/l

0.15

1388

11053

(3013512) EKG study

4374

48655

0.81

27.95

3.7

4.0

0.91

0.76

1.44

129

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

823

5324

1.52

27.09

3.0

3.5

65.31

44.59

mg/l

0.59

752

4499

(3034860) Kappa light chains.free [Mass/volume] in Serum

822

5335

1.52

26.64

3.0

3.5

103.40

60.38

mg/l

0.44

750

4504

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

435

2425

1.75

26.13

2.3

1.9

24.14

25.30

ug/l

0.14

430

2380

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

361

6111

0.56

26.11

4.9

4.1

24.51

24.67

mmol/l

0.54

340

5607

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

567

3396

1.63

26.05

1.8

1.5

0.24

g/l

0.01

542

3243

(3037756) Immunofixation for Serum or Plasma

543

3218

1.65

26.02

1.4

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

606

3691

1.61

26.01

1.5

11.84

6.41

iu/ml

0.22

117

756

(3033942) Copper [Moles/time] in 24 hour Urine

8.05

25.78

2.0

1.0

1.62

0.24

umol/24h

0.95

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

737

4728

1.53

25.21

2.8

3.4

2.98

4.43

ratio

0.62

424

2707

(3019230) Fractional oxyhemoglobin in Venous blood

541

3243

1.63

24.78

3.2

3.0

60.53

63.02

1.63

541

3225

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

578

3525

1.61

24.68

1.7

1.5

1.22

1.17

g/l

3.01

555

3379

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3291

26715

1.24

24.55

1.9

1.8

1.56

1.45

mg/l

0.65

2655

21101

(3022145) Colonoscopy Study observation

2001

15314

1.30

24.30

1.5

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

837

2.24

23.97

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

550

3350

1.61

23.62

1.9

11.55

12.12

mg/l

0.85

513

3155

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

371

6064

0.58

23.55

2.3

2.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

442

2561

1.69

23.12

1.3

1.2

1.57

4.30

u/ml

1.42

173

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

493

2947

1.63

22.86

1.3

1.2

6.72

6.09

u/ml

0.07

276

(40759836) Histone Ab [Presence] in Serum by Immunoblot

186

813

2.22

22.70

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

766

2.24

22.14

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

561

3493

1.57

21.95

1.8

1.7

—

(4024509) Urine culture

808

5440

1.46

21.79

2.0

1.9

—

(3018333) Ribosomal P Ab [Presence] in Serum

173

747

2.25

21.76

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

488

2951

1.62

21.61

1.3

1.2

5.80

6.94

u/ml

0.22

424

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

800

2.20

21.52

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

181

801

2.19

21.45

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

507

3105

1.60

21.30

1.3

1.2

16.01

36.85

u/ml

1.32

152

(3036489) Thrombin time

725

4818

1.47

20.91

2.2

2.1

22.00

21.51

0.73

651

4337

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

201

937

2.08

20.87

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

337

1874

1.75

20.50

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

337

1875

1.75

20.46

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

337

1875

1.75

20.46

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

337

1875

1.75

20.46

1.7

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

840

5776

1.43

20.22

3.4

3.7

4.47

4.43

pmol/l

0.45

764

5225

(3022313) Gas panel - Capillary blood

545

7852

0.66

20.08

4.7

4.1

—

(4035726) Immunohistochemistry procedure

1506

11364

1.31

20.07

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

353

5607

0.60

20.02

2.0

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

174

780

2.17

20.01

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

612

3965

1.51

20.00

2.4

2.3

90.82

88.12

2.33

597

3827

(3000570) Elastase.pancreatic [Mass/mass] in Stool

614

3992

1.50

19.73

1.5

259.04

258.00

ug/g

0.04

381

2433

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

146

3.84

19.47

1.1

1.0

—

(3000330) Specific gravity of Urine by Test strip

949

6728

1.39

19.13

3.9

3.4

1.02

ratio

0.83

867

6168

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2375

19053

1.24

19.11

1.3

30.79

36.77

iu/ml

1.03

699

5588

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

469

2902

1.58

18.90

1.3

1.2

1.92

10.81

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

399

2387

1.63

18.50

1.1

7.36

7.91

eliau/ml

0.06

263

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

866

11292

0.72

18.33

4.4

3.9

5.07

5.11

kpa

0.71

835

10752

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

555

3592

1.51

18.25

2.7

2.5

202.72

203.45

0.06

529

3421

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

155

692

2.17

18.06

1.9

1.4

6.14

6.60

u/l

0.39

137

602

(3009343) pH of Capillary blood

840

10979

0.72

18.04

4.4

3.9

7.42

0.01

702

9168

(3006245) CD3-CD19+ cells/cells in Blood

104

393

2.56

17.67

1.8

2.1

10.76

11.10

0.08

360

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1082

7932

1.34

17.60

5.0

4.2

47.47

47.03

0.24

1074

7818

(40760892) CBC W Ordered Manual Differential panel - Blood

3224

26874

1.20

17.53

6.0

4.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

135

577

2.27

17.50

2.9

1.8

100.73

111.36

umol/l

0.17

282

(3020891) Body temperature

1001

7275

1.35

17.24

5.0

36.90

°c

0.06

996

7194

(3009508) Creatinine [Moles/volume] in Urine

5766

50551

1.16

17.04

3.7

3.6

8.13

8.15

mmol/l

0.18

5152

42243

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3908

33232

1.18

16.83

2.8

2.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1852

14649

1.25

16.75

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

378

2289

1.61

16.72

1.5

1.4

7.70

13.15

u/ml

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1319

10047

1.29

16.26

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

393

2425

1.58

16.08

1.2

0.68

0.77

0.13

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

732

9606

0.72

16.07

4.2

3.8

1.73

1.63

mmol/l

0.32

536

7009

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

102

401

2.46

16.00

1.8

2.1

31.24

30.24

0.24

378

(40761536) Microorganisms panel - Urine sediment

798

10317

0.73

15.93

4.9

4.0

—

(3000494) Fungus identified in Specimen by Culture

1986

15926

1.23

15.78

1.6

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

401

2498

1.56

15.75

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

307

2.65

15.32

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

981

7235

1.33

15.29

4.4

3.7

25.04

25.08

mmol/l

0.13

948

7011

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1344

10375

1.27

14.87

9.8

8.8

24.55

24.62

mmol/l

0.29

1337

10303

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

422

2716

1.51

14.32

1.2

1.3

435.38

265.34

titre

0.52

191

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5161

45281

1.15

14.31

3.3

3.4

1669.41

1597.97

ng/l

0.46

4638

39597

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

423

2728

1.51

14.22

1.2

1.3

60.00

160.00

titre

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1206

9235

1.28

14.22

1.8

—

(3002256) Pathology report gross observation

2171

17750

1.21

14.14

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

928

6870

1.32

14.09

2.5

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

521

3517

1.44

13.92

3.0

3.5

—

1.29

—

(3025941) Bacteria identified in Stool by Culture

816

5940

1.34

13.91

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

795

5782

1.34

13.63

2.9

3.1

0.32

0.34

iu/ml

0.81

441

3180

(4146454) Self-monitoring of blood glucose

1860

0.44

13.54

2.7

2.8

—

(40768797) Stomach Pathology biopsy report

2158

17703

1.21

13.52

1.3

—

(3022621) pH of Urine by Test strip

1235

9544

1.27

13.51

2.7

2.5

5.96

5.99

0.64

918

6655

(3014765) Yersinia sp identified in Stool by Organism specific culture

446

2941

1.48

13.47

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

602

4196

1.40

13.46

2.9

2.5

3.58

3.61

g/l

0.16

578

4045

(3045414) Leukocytes [Presence] in Urine

1569

12481

1.24

13.33

2.2

2.1

0.01

estimate

0.02

377

2462

(3020191) Ethanol [Moles/volume] in Serum or Plasma

222

1246

1.73

13.24

1.7

1.4

0.82

1.30

promille

5.46

197

984

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

214

1190

1.75

13.19

1.8

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

349

2.41

13.15

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

148

734

1.95

13.14

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

445

2950

1.47

13.10

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

441

2927

1.47

12.90

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

272

2.60

12.89

1.6

2.2

0.78

2.10

e9/l

0.52

136

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

431

2852

1.47

12.81

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

431

2852

1.47

12.81

1.4

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

507

3470

1.42

12.60

4.7

3.8

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

106

3.65

12.60

1.5

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2134

17623

1.20

12.36

1.3

11.02

12.61

u/ml

0.23

751

6566

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

604

4279

1.38

12.28

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

165

870

1.84

12.19

1.5

1.4

13.54

14.24

umol/l

0.57

155

805

(3012516) Albumin [Mass/volume] in Urine

5522

49051

1.14

12.18

3.6

3.7

52.82

54.53

mg/l

0.22

3988

33558

(3005322) IgE [Units/volume] in Serum or Plasma

905

6826

1.30

12.00

1.4

1.3

311.74

301.12

u/ml

0.06

850

6362

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

324

2.39

11.89

1.4

1.6

10.79

9.61

ug/l

0.98

324

(3006576) Bicarbonate [Moles/volume] in Blood

119

570

2.02

11.71

7.3

6.7

25.51

24.90

mmol/l

0.73

104

518

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1245

14618

0.80

11.66

3.5

3.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

747

5514

1.32

11.60

1.8

43.48

43.80

nmol/l

0.15

737

5321

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

269

1650

1.58

11.43

1.3

1.2

4.02

4.16

u/ml

0.05

133

778

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

144

745

1.87

11.33

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

272

1678

1.57

11.28

1.3

1.2

3.10

4.12

u/ml

0.54

108

626

(3021387) Prolactin [Units/volume] in Serum or Plasma

420

2839

1.44

11.22

1.9

1.8

320.88

276.19

mu/l

1.07

395

2619

(3020682) Albumin/Creatinine [Ratio] in Urine

5618

50151

1.13

11.15

4.2

4.4

9.24

9.47

mg/mmol

0.12

3932

33244

(3026389) Candida sp identified in Specimen by Organism specific culture

234

1399

1.62

11.07

1.4

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

591

4251

1.36

10.95

4.5

4.8

3.92

3.94

mmol/l

0.46

585

4213

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

333

2162

1.50

10.95

1.2

1.3

214.70

204.64

miu/ml

0.16

786

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

16.41

10.94

2.3

22.11

25.46

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

494

2.06

10.88

3.2

2.8

10.53

10.21

kpa

0.37

105

494

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

495

2.05

10.83

3.2

2.8

4.88

4.81

kpa

0.19

105

495

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

512

3608

1.38

10.79

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

204

1190

1.66

10.65

3.2

3.1

46.29

55.06

mg/l

0.24

155

883

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

463

2.07

10.45

1.2

—

(3011648) Oxygen content in Venous blood

248

1527

1.58

10.41

3.0

2.5

10.63

10.94

0.53

248

1520

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

238

2.52

10.39

1.1

960.00

930.36

titre

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2806

24018

1.16

10.30

1.7

1.8

1175.85

1125.29

nmol/l

2.22

2297

18217

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

366

2452

1.45

10.29

1.9

1.8

4.94

10.70

iu/l

0.70

119

913

(3018405) Lactate [Moles/volume] in Arterial blood

692

5143

1.31

10.26

4.2

4.5

1.34

1.44

mmol/l

1.64

675

5044

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

285

1826

1.52

10.02

1.5

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

611

4486

1.33

9.89

1.1

535.31

172.97

titre

0.57

140

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.50

9.87

3.8

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

365

2.17

9.85

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1008

7893

1.25

9.84

2.4

2.5

26.92

21.60

au/ml

0.96

718

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

372

2.16

9.80

1.2

1.3

3.54

4.17

umol/l

0.96

325

(3023323) Follitropin [Units/volume] in Serum or Plasma

386

2637

1.42

9.79

1.4

21.37

24.69

iu/l

1.49

324

2206

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

261

1651

1.53

9.75

1.4

1.3

287.36

339.72

pmol/l

0.35

225

1344

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

596

4378

1.33

9.63

1.9

194.57

200.42

pmol/l

0.63

561

4098

(3035320) C reactive protein [Mass/volume] in Body fluid

169

966

1.70

9.58

3.0

2.7

36.12

32.90

mg/l

0.40

130

711

(3011985) Renin [Units/volume] in Plasma

277

1789

1.50

9.41

1.5

1.4

65.03

66.07

mu/l

0.03

253

1588

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

412

2.07

9.31

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

279

2.29

9.01

1.5

1.3

0.23

0.26

mmol/l

0.11

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

491

1.95

8.95

1.5

1.7

8.00

10.60

nmol/l

0.17

415

(3004716) Salmonella sp identified in Stool by Organism specific culture

576

4257

1.32

8.94

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

1562

1.52

8.68

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

146

825

1.71

8.68

2.2

2.7

204.69

246.23

e6/l

1.76

118

726

(3024891) Influenza virus A+B Ag [Presence] in Specimen

408

2881

1.38

8.58

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

931

7360

1.24

8.36

1.3

1.2

—

(3008898) HLA-B27 [Presence]

401

2839

1.37

8.31

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

271

2.25

8.29

2.9

2.8

200.20

126.65

au/ml

0.54

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

917

7245

1.24

8.28

1.3

51.85

54.54

au/ml

0.14

495

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

303

2.17

8.22

3.7

3.8

7.98

7.75

mg/l

0.10

246

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

239

1543

1.50

8.20

4.1

3.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

141

810

1.69

7.93

2.9

2.8

37.14

36.55

0.14

424

(21494890) Protein electrophoresis panel - 24 hour Urine

257

1696

1.47

7.93

2.0

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

250

1641

1.48

7.92

1.4

1.3

0.65

2.58

nmol/l

0.90

242

1577

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

190

1180

1.56

7.81

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

254

1678

1.47

7.80

1.3

0.17

0.29

nmol/l

1.25

136

(3010838) Calcium [Moles/time] in 24 hour Urine

277

1861

1.44

7.79

2.0

1.9

4.94

4.91

mmol/24h

0.05

253

1633

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

343

2402

1.39

7.64

6.6

6.1

12.30

11.64

mg/l

1.83

321

2221

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

704

1.72

7.58

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

125

704

1.72

7.58

1.2

517.04

399.67

u/l

0.24

120

651

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

719

1.71

7.56

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

207

1325

1.51

7.44

3.9

13.83

12.82

index

0.71

133

773

(4195642) Thrombophilia screening test

232

1522

1.48

7.40

1.2

—

(4268621) Lupus anticoagulant assay

181

1132

1.55

7.25

2.5

2.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

384

2774

1.34

7.06

1.3

1.4

57.53

22.79

e6/l

0.51

271

2097

(3051387) C reactive protein [Mass/volume] in Capillary blood

378

2726

1.35

7.03

3.7

3.5

32.10

30.01

mg/l

0.55

288

1887

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

388

2810

1.34

7.02

1.4

1.5

419.21

1479.35

e6/l

3.47

293

2263

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

137

809

1.64

7.00

2.0

2.5

494.96

524.67

e6/l

0.30

107

673

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

394

2866

1.34

6.92

1.3

3.92

3.87

mmol/l

0.31

370

2714

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

122

705

1.67

6.79

3.3

2.7

204.37

202.90

u/l

0.07

122

694

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

523

3967

1.28

6.77

1.7

1.6

25.58

23.23

u/ml

0.20

133

856

(3043410) Blood group antigens tested for on Red Blood Cells

388

1.92

6.76

2.1

2.0

—

(3004775) Volume in Urine collected for unspecified duration

1358

0.54

6.72

2.3

2.4

738.98

692.32

0.39

893

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

460

3435

1.30

6.72

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

114

649

1.70

6.71

31.7

31.6

117.57

112.47

ug/l

0.35

100

543

(3038177) Helicobacter pylori Ab [Presence] in Serum

236

1587

1.44

6.67

1.2

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

434

3224

1.31

6.60

1.3

536.10

593.97

mg/l

1.35

411

3078

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

186

2.34

6.58

1.4

66.42

71.96

0.45

155

(40757494) Bilirubin.total [Moles/volume] in Blood

129

763

1.64

6.58

2.2

2.3

43.42

33.00

umol/l

—

(3017732) Neutrophils [#/volume] in Blood

1876

16110

1.14

6.36

3.2

4.54

4.80

e9/l

1.06

1718

13621

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

148

914

1.57

6.33

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

467

1.80

6.30

7.8

7.7

5.94

6.02

kpa

0.29

416

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.58

6.24

1.6

2.49

1.44

mg/l

0.33

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.58

6.24

1.6

4.99

1.20

mg/l

1.04

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.51

6.09

1.6

3.81

0.64

mg/l

0.96

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

732

5849

1.22

6.00

2.9

2.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

251

3324

0.72

6.00

4.9

4.4

5.02

4.97

kpa

0.44

244

3253

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.60

5.99

1.3

1.1

—

(3012501) Base excess in Blood by calculation

251

3323

0.72

5.99

4.8

4.4

2.88

2.49

mmol/l

0.85

167

2239

(3013005) Retinol [Moles/volume] in Serum or Plasma

483

1.76

5.94

2.2

1.9

1.93

1.97

umol/l

0.15

446

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

710

5662

1.22

5.94

1.2

102.66

127.05

u/ml

1.16

273

1919

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

226

1547

1.42

5.86

1.2

1.1

114.42

111.92

0.58

211

1400

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

558

1.70

5.83

3.2

2.6

0.61

mmol/l

0.26

558

(3027315) Oxygen [Partial pressure] in Blood

254

3337

0.73

5.78

5.0

4.4

8.57

8.49

kpa

0.33

247

3265

(3036782) Glucose [Moles/volume] in Pleural fluid

253

1770

1.39

5.78

1.3

1.4

6.27

6.22

mmol/l

0.08

235

1645

(40768443) Skin Pathology biopsy report

721

5775

1.21

5.78

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

905

7408

1.19

5.75

2.1

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

209

1417

1.43

5.72

1.3

1.4

—

nmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

840

6834

1.20

5.71

2.0

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.22

5.62

1.0

1.2

1.63

1.56

iu/ml

0.07

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

138

866

1.54

5.56

1.1

1.2

110.96

103.22

pmol/l

0.39

138

866

(3026250) Tacrolimus [Mass/volume] in Blood

109

647

1.63

5.55

41.2

39.2

7.37

7.09

ug/l

0.88

582

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

1.47

0.63

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

0.42

0.43

mg/l

0.03

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

2.05

1.87

mg/l

0.05

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

2.86

2.60

mg/l

0.05

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

6.24

0.48

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

1.32

1.88

mg/l

0.25

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.40

5.53

1.6

6.13

2.80

mg/l

0.60

(3023419) Bacteria identified in Sputum by Culture

290

2090

1.35

5.52

2.3

2.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

441

3365

1.27

5.52

3.0

3.6

545.26

1303.01

u/ml

0.88

404

3070

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.27

5.50

1.6

0.50

0.33

u/l

—

(3018133) Calcium [Moles/volume] in Urine

183

2.22

5.49

2.2

2.0

2.93

2.60

mmol/l

0.34

165

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

101

2.68

5.47

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

124

763

1.57

5.45

1.3

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

518

1.70

5.44

2.4

1.7

3849.89

13745.92

u/ml

0.72

(3003129) Base excess in Capillary blood by calculation

150

2134

0.67

5.43

2.3

0.25

0.11

mmol/l

0.21

142

2056

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

124

764

1.57

5.42

1.3

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

315

1.90

5.40

2.0

2.2

7.54

8.88

mg/l

1.23

266

(3044242) Glucose [Moles/volume] in Arterial blood

142

904

1.52

5.37

1.7

2.0

8.02

8.16

mmol/l

0.17

142

904

(3052592) Norovirus Ag [Presence] in Stool

237

2.04

5.30

1.4

1.3

—

(3042517) Benzodiazepines panel - Urine

2.99

5.25

1.8

3.0

—

(3016750) Collection duration of Urine

964

0.53

5.23

2.3

495.66

497.63

min

0.04

699

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

247

1753

1.37

5.21

2.5

2.2

4143.27

5178.57

u/l

0.19

608

(3017704) Immunofixation for Urine

131

826

1.53

5.19

1.4

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

443

3409

1.26

5.19

1.8

1.7

—

32.21

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

180

1211

1.44

5.19

1.2

96.45

96.83

0.06

166

1125

(3028271) Lactate [Moles/volume] in Capillary blood

181

2465

0.70

5.18

2.1

1.9

1.89

1.73

mmol/l

0.95

172

2398

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

153

998

1.48

5.17

1.3

1.2

9.31

9.60

mmol/l

0.33

140

923

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.95

5.13

1.1

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

5.12

1.1

1.2

0.28

0.36

iu/ml

0.27

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

425

3262

1.26

5.10

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

268

3419

0.75

5.06

2.9

2.8

15.94

16.47

1.94

259

3348

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

575

1.63

5.01

1.1

19.11

21.50

u/ml

0.26

210

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

174

1173

1.44

4.98

1.1

2.10

4.14

eliau/ml

2.94

473

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

514

4044

1.23

4.96

1.9

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.51

4.90

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

386

2944

1.27

4.90

1.6

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

831

6859

1.18

4.84

2.1

2.0

3.04

2.17

ug/l

0.73

767

6112

(3045142) Bone marrow Pathology biopsy report

242

1735

1.35

4.82

1.3

1.4

—

(3024932) HLA-DR beta [Type]

427

1.72

4.82

1.1

—

(3045788) Cell count panel - Pleural fluid

253

1828

1.34

4.79

1.5

—

(1761868) Lipid panel - Serum or Plasma

4193

42867

0.92

4.75

3.4

3.5

—

(21494434) Karyotype in Bone marrow

195

1356

1.39

4.71

1.2

—

(3024471) HLA-A [Type]

438

1.70

4.68

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

225

1605

1.36

4.65

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

771

1.52

4.62

1.1

6.60

6.49

nmol/l

0.01

157

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

250

1.93

4.62

1.2

1.3

28.94

334.34

u/l

1.02

184

(3028707) Methadone [Presence] in Urine by Screen method

173

1185

1.41

4.57

4.0

2.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

552

1.61

4.57

2.1

1.7

27.69

28.22

umol/l

0.15

523

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

206

1454

1.37

4.56

1.3

0.29

0.22

nmol/l

0.29

171

1214

(3042733) HLA Ab [Presence] in Serum

479

1.65

4.53

5.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

188

1309

1.39

4.52

1.5

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

1447

12494

1.13

4.51

5.2

4.3

0.96

0.95

0.05

497

4119

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

465

3662

1.23

4.49

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.96

4.48

3.0

2.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

308

1.82

4.47

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

415

1.70

4.47

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

145

967

1.45

4.44

1.9

2.0

73.23

70.94

0.96

137

926

(3038071) Oxygen [Partial pressure] in Mixed venous blood

416

1.70

4.43

7.7

7.6

5.40

5.47

kpa

0.10

416

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

139

920

1.46

4.43

1.8

2.0

14.27

16.50

1.70

131

897

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.36

4.39

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

410

1.70

4.38

1.1

—

(3042631) Mycobacterium sp identified in Specimen

173

2294

0.72

4.29

3.2

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

600

1.56

4.27

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

197

1403

1.36

4.16

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

227

1656

1.33

4.10

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

195

1391

1.36

4.09

1.1

2.57

2.95

0.25

175

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

129

1768

0.70

3.94

2.4

2.2

19.72

27.33

mg/l

1.08

692

(3023410) Appearance of Cerebral spinal fluid

166

1165

1.38

3.87

1.4

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.83

3.87

4.7

2.5

—

(3014271) Vancomycin [Susceptibility]

778

0.56

3.86

3.3

2.9

—

(4198724) Urine methamphetamine measurement

345

1.71

3.86

3.1

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

373

2921

1.24

3.85

1.6

1.4

—

(3024263) Appearance of Synovial fluid

110

717

1.48

3.84

1.5

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

490

3946

1.20

3.84

1.8

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

3.83

1.3

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.61

3.79

1.1

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

109

712

1.48

3.78

1.1

3.20

4.29

iu/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

478

3850

1.20

3.75

4.3

3.2

1.59

1.65

mmol/l

0.71

469

3753

(3000475) Leukocytes [#/volume] in Synovial fluid

452

3625

1.21

3.71

1.7

1.6

17975.58

15929.01

e6/l

0.31

321

2588

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

188

1356

1.34

3.71

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

577

1.52

3.65

1.2

50.33

62.13

—

(3051339) Copper [Moles/volume] in Blood

2.78

3.63

1.2

18.22

16.03

umol/l

1.09

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

287

2201

1.26

3.59

2.9

3.4

56.26

71.22

u/ml

0.38

277

2123

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

331

1.69

3.58

7.6

6.9

10.08

10.60

0.93

331

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

101

2.29

3.51

1.9

1.7

—

(3011412) CD3 cells [#/volume] in Blood

173

1244

1.35

3.50

2.0

2.4

1190.09

1087.31

e6/l

0.72

145

1126

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.34

3.50

1.3

1.1

8.74

12.03

u/l

0.47

(3020911) Cortisol [Moles/time] in 24 hour Urine

348

1.67

3.49

1.2

1.6

737.11

251.03

nmol/24h

0.41

348

(3014148) Varicella zoster virus Ab [Titer] in Serum

186

1353

1.33

3.49

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

106

706

1.45

3.37

1.5

1.3

—

(3002619) Bacteria identified in Specimen by Culture

337

1.66

3.37

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

237

1793

1.28

3.35

4.4

3.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

418

3368

1.20

3.31

1.4

8.51

8.34

u/l

0.11

336

2668

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

176

1.92

3.28

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

100

663

1.46

3.27

3.0

3.6

1.11

1.27

0.49

100

663

(3038515) Glucose [Moles/volume] in Venous blood

402

3239

1.20

3.20

4.5

3.4

7.26

7.71

mmol/l

3.15

396

3157

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

143

1015

1.36

3.19

2.1

1.8

—

(4015189) Microbial culture of sputum

433

0.47

3.18

3.8

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

294

2297

1.24

3.18

1.5

1646.02

3167.67

e6/l

1.79

201

1649

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1513

13366

1.10

3.16

2.5

2.4

7.72

8.27

ug/l

0.50

1402

11906

(3010421) pH of Blood

413

4732

0.84

3.16

4.4

4.1

7.41

0.85

407

4667

(3001218) Citrate [Mass/time] in 24 hour Urine

4.57

3.13

1.4

1.5

300.11

378.11

mg/24h

—

(3017354) Segmented neutrophils/Leukocytes in Blood

139

1798

0.74

3.06

3.6

58.94

58.41

0.11

113

1538

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

378

1.58

3.02

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

378

1.58

3.02

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

378

1.58

3.02

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

378

1.58

3.02

1.1

—

(3047189) Immunofixation for 24 hour Urine

110

760

1.40

2.92

1.6

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

110

2.11

2.91

1.7

1.8

1.24

1.33

umol/l

0.48

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1282

0.71

2.90

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1013

10823

0.90

2.89

5.1

4.3

1.22

mmol/l

1.67

939

9362

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

148

1074

1.33

2.89

1.6

29.07

26.86

u/ml

0.16

218

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

138

991

1.35

2.89

1.5

1.4

0.23

0.28

nmol/l

1.10

105

751

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

333

2667

1.21

2.87

1.2

1.1

4.79

3.30

0.49

280

(3013166) Neutrophils/Leukocytes in Synovial fluid

422

1.53

2.85

1.6

1.3

55.87

59.85

0.38

362

(3003181) Sodium [Moles/volume] in Urine

309

2461

1.22

2.82

1.4

58.80

63.66

mmol/l

1.47

260

1971

(3035611) Eosinophils/Leukocytes in Synovial fluid

2.18

2.78

2.0

1.4

0.61

0.96

0.45

(3001729) Color of Synovial fluid

106

2.09

2.76

1.9

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

274

1.66

2.76

1.3

0.47

1.09

mmol/l

1.44

183

(3034426) Prothrombin time (PT)

342

1.58

2.74

1.3

27.93

28.73

0.79

342

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

238

1.70

2.74

1.7

80.66

90.24

au/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

269

2120

1.23

2.74

2.3

2.5

1.12

1.29

g/24h

0.75

175

1288

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.05

2.72

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

276

1.64

2.69

3.1

5.1

49.23

72.84

u/l

0.77

269

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

158

1171

1.30

2.69

1.8

4.86

4.21

mg/l

0.55

152

1121

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

349

2827

1.20

2.69

1.6

1.3

40.71

34.95

u/l

0.27

312

2436

(3005011) Chlamydia sp Ab [Titer] in Serum

121

1.99

2.66

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

637

1.41

2.63

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

693

5927

1.13

2.63

2.6

2.3

613.58

628.19

ug/l

0.04

669

5683

(3041672) Baker's yeast Ab [Presence] in Serum

2.67

2.62

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

198

1.76

2.61

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

740

0.64

2.58

2.9

2.4

—

(3021440) Promyelocytes/Leukocytes in Blood

1346

11952

1.09

2.56

5.3

4.3

0.11

0.12

0.02

396

3610

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

279

0.41

2.55

2.4

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

129

1636

0.76

2.54

4.2

3.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

604

0.61

2.51

1.3

10.16

242.65

ug/l

2.93

307

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

252

1.65

2.50

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

112

799

1.35

2.50

1.2

1.3

2.79

2.03

u/ml

0.22

477

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

308

2488

1.20

2.48

1.7

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

551

6044

0.87

2.47

4.2

3.1

24.48

24.51

mmol/l

0.07

539

5937

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

524

1.44

2.47

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

167

1263

1.28

2.47

1.9

1.7

—

(3025159) Blasts/Leukocytes in Blood

1350

12015

1.09

2.45

5.6

4.4

0.12

0.26

1.69

371

3462

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

217

1.69

2.44

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.10

2.44

2.2

2.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

958

0.69

2.42

1.7

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

116

837

1.34

2.42

1.3

1.29

1.26

nmol/l

0.10

100

603

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

333

2717

1.19

2.40

2.4

2.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

424

1.48

2.40

1.4

1.3

168.00

135.16

nmol/l

0.31

316

(3000093) Morphology [Interpretation] in Blood Narrative

197

1526

1.25

2.40

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

161

1.80

2.38

1.3

1.1

60.23

65.01

ug/l

0.53

161

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

287

2313

1.20

2.38

4.3

4.1

9.49

10.65

pmol/l

0.87

287

2308

(4034850) Laboratory test

462

3876

1.15

2.36

13.7

11.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

230

1816

1.23

2.35

1.3

1.4

380.42

544.42

u/l

1.28

218

1724

(3033099) Centromere Ab [Titer] in Serum

287

1.58

2.35

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

490

1.44

2.34

2.9

3.1

22.71

24.31

mu/l

0.14

459

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

348

3929

0.85

2.33

2.2

2.4

139.86

129.43

ug/min

0.15

220

2363

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

592

0.62

2.33

3.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

591

0.62

2.32

3.2

2.0

—

(3032641) Amino acids panel - Urine

6.03

2.31

1.6

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

135

1.86

2.30

1.3

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

589

1.39

2.30

1.2

1.1

1.09

1.07

ratio

0.70

479

(3043238) Trisomy 21 risk [Likelihood] in Fetus

739

0.66

2.26

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

123

906

1.31

2.25

1.4

1.5

116.98

185.72

pmol/l

1.20

123

886

(3014891) Appearance of Pleural fluid

223

1.65

2.23

1.7

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

109

791

1.33

2.22

6.0

59.64

66.02

u/ml

0.10

268

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

570

4875

1.13

2.22

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

390

3252

1.16

2.19

2.5

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

439

3693

1.15

2.19

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

217

1.65

2.19

7.9

6.1

28523.60

5578.64

iu/ml

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.41

2.18

3.7

4.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1083

0.73

2.18

1.6

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

273

0.46

2.17

2.3

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

720

0.67

2.16

1.5

—

(3005033) Fetal Nuchal fold Thickness US

708

0.67

2.16

1.6

1.5

1.26

1.27

0.12

509

(3002179) Metamyelocytes/Leukocytes in Blood

1333

11940

1.08

2.11

5.1

4.1

0.75

0.71

0.26

439

3995

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

374

1.47

2.09

1.3

0.33

0.30

g/l

1.60

305

(3003434) Protein [Mass/volume] in Pleural fluid

317

2612

1.17

2.09

1.5

30.96

44.02

g/l

0.58

278

2365

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

220

1.62

2.09

1.5

1.6

0.50

0.38

ug/l

1.27

152

(3002079) Sodium [Moles/time] in 24 hour Urine

568

1.38

2.07

1.5

1.3

148.63

181.48

mmol/24h

3.48

568

(4027681) Cerebrospinal fluid IgG ratio and IgG index

569

1.38

2.06

1.1

1.2

1.24

0.57

ratio

0.44

332

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

484

4120

1.14

2.05

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

321

1.50

2.04

1.4

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

256

2081

1.19

1.99

3.1

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

591

0.65

1.99

3.1

2.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.38

1.98

1.1

—

(44813793) Dust mix specific IgE antibody measurement

656

1.34

1.98

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

818

0.71

1.97

2.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

818

0.71

1.97

2.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

818

0.71

1.97

2.5

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

624

1.35

1.96

1.0

1.1

6.07

9.43

iu/ml

1.73

170

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

192

1523

1.22

1.94

1.1

17.79

18.36

au/ml

0.03

334

(3016135) IgD [Mass/volume] in Serum

2.97

1.93

1.0

1.2

44.13

47.13

mg/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.97

1.93

1.3

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.93

1.91

4.1

3.7

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

2.71

1.91

1.0

176.22

592.96

u/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

786

1.30

1.90

2.3

2.0

—

(1616796) Gas panel - Central venous blood

335

3724

0.86

1.90

4.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

196

1.63

1.89

1.0

1.2

2.46

0.72

umol/24h

0.47

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

119

898

1.28

1.88

1.3

53.75

91.41

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

122

924

1.28

1.87

1.3

403.75

497.64

titre

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

258

1.53

1.86

1.1

1.2

50.79

91.68

mg/l

0.28

186

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

1.81

1.85

1.4

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

817

0.72

1.82

2.5

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

154

1.69

1.81

1.2

0.02

0.36

u/ml

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.07

1.80

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1069

0.76

1.80

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

981

0.75

1.80

1.6

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.11

1.78

8.4

11.2

110.64

104.73

g/l

0.55

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

170

1.65

1.77

1.7

1.6

—

(3049233) Organic acids panel - Urine

4.02

1.76

1.4

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

703

1.31

1.76

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

131

0.37

1.75

3.6

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

545

1.35

1.75

1.1

1521.79

1572.67

miu/ml

0.14

545

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.94

1.72

1.1

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

113

1.79

1.72

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

279

1.49

1.72

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

209

0.46

1.71

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

682

1.30

1.69

1.1

—

7.80

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

128

1.73

1.69

1.0

254.80

399.21

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

119

912

1.26

1.69

1.2

36.13

35.87

mmol/l

0.04

107

800

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

251

2821

0.86

1.69

1.9

1.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

360

1.42

1.69

1.4

1.3

42.71

31.24

1.32

238

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

156

1235

1.22

1.66

1.2

1.1

0.68

2.27

iu/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

158

0.43

1.66

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

181

1.60

1.65

1.4

—

(40768446) Kidney Pathology biopsy report

601

1.32

1.65

2.0

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

117

899

1.26

1.64

1.3

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

174

1.61

1.63

1.2

1.4

273920.17

178532.34

nmol/l

0.12

149

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

882

1.26

1.63

1.3

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

189

2165

0.84

1.61

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

781

1.27

1.61

1.0

1.1

258.14

330.08

mg/l

3.58

688

(3016228) CD19 cells/cells in Blood

561

0.69

1.59

2.0

10.30

8.27

0.31

544

(3024522) Salmonella sp identified in Specimen by Organism specific culture

146

1710

0.82

1.59

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

146

1710

0.82

1.59

1.6

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

168

1.61

1.59

2.3

2.2

15.39

17.75

umol/l

0.68

168

(4094501) Cardiovascular stress test using bicycle ergometer

446

3852

1.12

1.57

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

802

1.26

1.56

2.0

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

334

1.42

1.55

1.3

1.2

16.84

13.24

pmol/l

0.38

139

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

310

1.43

1.55

1.2

1.5

13.86

15.67

pmol/l

1.40

258

(3041918) Cholesterol [Moles/volume] in Pleural fluid

360

1.39

1.52

1.3

1.2

1.71

1.50

mmol/l

0.70

234

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

931

0.77

1.51

1.5

60.99

59.76

ug/l

0.07

774

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

297

0.58

1.49

3.4

2.4

11.82

7.73

mmol/l

0.56

186

(3020491) Glucose [Moles/volume] in Blood

118

920

1.24

1.48

1.6

1.9

7.32

7.15

mmol/l

0.23

630

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

330

1.40

1.47

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

140

1630

0.83

1.46

1.5

1.6

1050.70

1005.86

mu/l

0.12

121

1355

(3026051) Granulocytes/Leukocytes in Pleural fluid

429

1.35

1.45

1.3

1.4

22.07

22.13

0.01

364

(3037692) Legionella sp identified in Specimen by Organism specific culture

546

1.31

1.45

1.5

—

(3016879) Cocaine [Presence] in Urine

297

2517

1.14

1.44

3.1

2.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

267

1.45

1.43

1.8

1.7

111.18

113.52

ug/l

0.05

215

(40768795) Lymph node Pathology biopsy report

151

1213

1.20

1.43

1.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

188

1541

1.18

1.43

1.1

2.96

4.08

u/ml

0.75

808

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

701

1.27

1.42

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

128

1.66

1.42

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.19

1.41

1.0

—

(3035880) pH of Pleural fluid

127

1006

1.22

1.40

1.2

1.3

7.43

7.39

2.01

717

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

350

1.38

1.39

1.3

1.2

113.12

110.07

0.26

315

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

107

1.71

1.38

1.1

81.94

80.68

ug/l

0.05

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1710

15711

1.06

1.36

9.3

7.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

141

1626

0.83

1.35

1.7

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

511

1.30

1.34

1.1

1.0

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

562

0.72

1.33

1.3

1.5

1.86

2.90

0.94

473

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

640

1.27

1.32

1.1

—

1.40

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.75

1.32

1.1

2.42

1.86

umol/24h

0.34

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

213

0.54

1.32

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

142

1631

0.84

1.31

1.7

1.4

—

(3044007) Cell count panel - Peritoneal fluid

522

1.29

1.30

2.7

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

142

1628

0.84

1.29

1.7

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

155

1264

1.18

1.28

2.3

2.4

24.67

28.20

iu/ml

0.10

162

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

668

0.75

1.28

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

668

0.75

1.28

1.4

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

128

0.45

1.28

2.8

2.2

0.90

0.65

ug/l

—

128

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.75

1.27

1.2

1.1

134.00

99.27

titre

0.55

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

851

0.78

1.26

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

187

1553

1.16

1.25

1.4

1.3

1.42

1.44

nmol/l

0.12

167

1412

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.02

1.24

1.0

1.1

—

mmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.71

1.24

1.9

1.5

—

(3027008) Opiates [Presence] in Urine

313

2695

1.12

1.23

3.0

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

312

2686

1.12

1.23

3.0

2.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

105

829

1.22

1.23

1.1

40.39

48.52

mg/l

1.03

703

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.05

1.22

1.1

0.03

0.10

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

394

3439

1.11

1.22

1.6

1.7

5.95

4.83

mg/l

0.56

305

2541

(37021550) Renin [Units/volume] in Plasma --upright

261

1.41

1.21

1.3

75.20

65.92

mu/l

0.13

191

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

181

1.49

1.21

2.0

3.5

39.25

41.53

umol/l

0.24

148

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

286

1.38

1.20

1.1

1.2

303.03

237.91

pmol/l

0.78

213

(3003740) Influenza virus B Ag [Presence] in Specimen

188

1568

1.16

1.20

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

313

0.65

1.20

1.6

1.4

1.17

1.18

mmol/l

0.11

313

(3028300) Cannabinoids [Presence] in Urine

313

2705

1.12

1.17

3.0

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

155

1745

0.86

1.16

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

862

0.79

1.16

1.5

1.23

1.14

ratio

0.30

521

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

509

4512

1.09

1.16

4.2

3.4

1.60

1.68

mg/l

1.22

484

4089

(3025018) Bordetella pertussis Ab [Titer] in Serum

586

1.25

1.12

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

110

0.44

1.12

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

187

1569

1.15

1.12

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

621

1.24

1.12

2.5

2.1

887.56

3979.00

e6/l

1.10

435

(3024869) Neuronal Ab [Presence] in Serum

274

1.37

1.11

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

683

1.23

1.10

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

212

0.59

1.09

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

174

1456

1.15

1.09

1.3

12.40

14.40

u/l

0.98

154

1355

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

171

1430

1.16

1.08

1.9

2.0

868.57

2686.86

titre

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.66

1.08

1.3

275.44

346.08

umol/24h

0.47

(3008401) Mugwort IgE Ab [Units/volume] in Serum

178

1495

1.15

1.06

1.1

0.47

1.03

u/ml

1.72

673

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

862

0.80

1.06

1.5

1.21

1.18

ratio

0.10

524

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

862

0.80

1.06

1.5

0.95

ratio

0.01

521

(3024316) Viscosity of Plasma

1.86

1.06

1.8

2.0

1.74

1.77

mpas

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

436

3859

1.09

1.05

2.3

2.4

125.68

131.17

g/l

4.42

331

2964

(3020874) Milk IgE Ab [Units/volume] in Serum

463

1.27

1.04

1.0

1.1

0.25

1.22

u/ml

1.24

156

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.30

1.04

5.4

5.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

240

2062

1.12

1.03

1.5

63785.22

63460.26

e6/l

0.00

127

1213

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

133

1096

1.17

1.03

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

422

1.28

1.02

1.1

103.48

97.31

0.90

337

(3027944) Amphetamines [Presence] in Urine

304

2650

1.11

1.01

2.9

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

390

0.72

1.01

1.3

1.2

—

(44806071) Cardiolipin IgM antibody measurement

158

1.47

0.99

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

571

1.23

0.98

2.5

2.4

56.08

55.25

umol/l

0.09

489

(3002331) Protein [Mass/volume] in Peritoneal fluid

399

1.28

0.98

1.4

24.91

43.26

g/l

0.63

305

(40758047) Lysozyme [Mass/volume] in Pleural fluid

169

0.57

0.98

1.0

1.2

6.42

8.71

mg/l

—

157

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.97

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

199

1.41

0.97

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.80

0.97

1.3

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.93

0.96

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

556

1.23

0.95

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

688

1.21

0.94

3.8

4.8

1674.43

1567.45

mg/l

0.02

501

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

113

0.51

0.94

2.0

5.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.82

0.91

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

203

1.38

0.88

1.1

1.21

6.53

u/ml

0.62

104

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

126

1050

1.16

0.88

1.2

1.3

2.30

2.21

mmol/l

0.24

116

977

(3005532) Lymphocytes/Leukocytes in Pleural fluid

649

0.80

0.87

1.3

1.5

68.89

63.26

0.65

533

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

466

0.77

0.87

2.4

3.0

29.09

29.08

umol/l

0.00

351

(3012989) Citrate [Moles/time] in 24 hour Urine

2.00

0.86

2.0

1.2

1.95

2.12

mmol/24h

—

(3050794) Legionella sp Ab [Presence] in Serum

131

1.47

0.86

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

590

1.21

0.86

1.1

1.12

1.15

u/l

0.12

270

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

210

1815

1.12

0.86

1.1

1.29

1.70

u/ml

0.30

112

1006

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

305

1.30

0.85

1.1

94.96

82.32

2.50

178

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

117

1.48

0.81

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

481

1.22

0.80

1.5

5.70

4.09

ug/l

0.36

416

(4133840) Spirometry

334

1.27

0.80

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

309

1.28

0.79

2.2

2.1

—

(4212803) Bone marrow aspirate examination

126

1.46

0.78

1.1

—

(3044927) Protein electrophoresis panel - Urine

178

1535

1.12

0.78

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

165

1417

1.12

0.77

1.5

1.3

71675.02

140983.56

e6/l

1.27

108

959

(3027456) Digoxin [Moles/volume] in Serum or Plasma

334

2975

1.08

0.76

3.0

3.1

0.81

0.80

nmol/l

0.15

275

2345

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

184

1592

1.12

0.76

1.9

1.7

—

(40758358) Immune stain study

0.00

0.76

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

135

1.43

0.76

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

111

1.48

0.76

1.2

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

346

1.26

0.75

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

451

1.22

0.74

1.0

1.1

0.43

1.50

u/ml

1.77

112

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.54

0.74

1.9

1.3

23.00

22.70

nmol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

781

0.84

0.73

1.6

—

(40757373) Influenza virus identified in Isolate

270

1.29

0.73

1.6

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

339

1.25

0.73

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.01

0.73

1.6

1.1

321.80

304.29

u/ml

—

(44806420) Estimation of glomerular filtration rate

1058

0.87

0.71

2.4

2.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

419

1.22

0.71

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.93

0.70

2.0

7.4

—

(36303858) Crystals [Presence] in Urine

1.93

0.70

1.2

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

578

1.19

0.70

1.3

1.4

3.22

3.52

mmol/l

0.30

534

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

839

0.85

0.70

4.9

3.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.64

0.67

9.3

11.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

191

2028

0.91

0.67

1.7

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

115

1.43

0.66

1.2

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

301

1.25

0.65

1.1

1.2

90.91

80.30

1.24

177

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

107

1.44

0.65

3.1

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

723

6653

1.05

0.65

1.8

1.7

—

(3004451) EKG impression Narrative

107

908

1.14

0.64

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

157

1.35

0.64

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

433

0.80

0.64

1.3

—

(3018291) Platelet Ab [Presence] in Serum

1.72

0.63

1.4

1.1

—

(3028433) Virus identified in Specimen by Culture

425

1.20

0.63

1.4

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

390

1.21

0.63

2.2

2.1

87.95

45.31

u/l

0.46

363

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

355

1.22

0.63

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

226

1.28

0.62

1.3

98.58

81.24

0.95

(3021901) Oxygen saturation in Capillary blood

347

3575

0.93

0.61

4.0

3.2

89.66

89.34

0.42

338

3476

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

117

1.40

0.61

1.5

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

269

0.75

0.61

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

132

0.66

0.60

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.60

0.0

1.1

—

164.70

—

(40768793) Breast Pathology biopsy report

1051

0.88

0.60

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.58

0.0

1.0

—

1.15

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

741

0.86

0.58

6.2

6.4

44.75

1371.73

u/ml

—

136

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

223

0.74

0.58

1.2

1.3

86.51

498.67

ng/l

—

154

(3007733) Chloride [Moles/volume] in Urine

1.70

0.57

1.2

1.3

103.17

80.83

mmol/l

—

(3022475) Manganese [Moles/volume] in Blood

1.48

0.57

1.3

1.4

0.16

umol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.65

0.56

1.2

1.0

8.47

8.57

mmol/l

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.61

0.55

1.0

1.4

0.93

1.97

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

330

2990

1.07

0.54

1.9

1.6

0.85

0.87

nmol/l

0.23

280

2520

(3040151) Glucose [Moles/volume] in Capillary blood

201

1788

1.09

0.54

10.0

10.2

7.54

7.39

mmol/l

0.28

170

1478

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

154

1.32

0.53

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

173

1530

1.09

0.53

1.4

1.2

—

(3005570) Glucose [Moles/volume] in Urine

113

1213

0.90

0.53

2.7

1.7

—

1.41

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

129

1.35

0.53

1.3

1.23

0.98

ml/s/173m2

0.64

(3017569) Oxygen content in Arterial blood

109

942

1.12

0.52

1.9

2.3

15.46

16.02

0.84

109

942

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.41

0.52

4.6

5.8

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

435

1.18

0.52

1.5

1.2

15.43

10.54

mm/h

1.04

435

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

435

1.18

0.52

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

525

1.16

0.52

2.1

4642.45

13856.14

e6/l

1.40

284

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

113

1.37

0.51

1.1

1.2

6.08

6.29

mmol/l

0.71

113

(3036670) Protein [Mass/volume] in Synovial fluid

462

0.83

0.51

1.3

1.2

42.03

41.12

g/l

0.18

232

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

314

0.80

0.51

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

324

0.80

0.50

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.24

0.50

1.2

69.40

73.44

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.41

0.49

1.0

3.65

7.30

u/ml

1.09

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

191

1.26

0.49

2.1

2.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.48

1.9

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

655

0.87

0.48

1.7

2.0

40.56

40.25

g/l

0.14

655

(40762887) Creatinine [Moles/volume] in Blood

106

0.64

0.48

1.7

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

183

1.27

0.48

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

183

1.27

0.48

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

183

1.27

0.48

1.1

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

279

0.79

0.47

1.4

1.5

5.33

10.35

—

142

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.39

0.47

2.0

1.9

1.41

1.60

mg/l

0.27

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

155

1375

1.09

0.47

1.5

1.4

12.68

13.08

u/l

0.37

148

1330

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

1.26

0.46

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.43

0.46

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

114

0.68

0.45

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

681

0.88

0.45

1.8

1.4

6.53

3.64

0.32

150

(3041806) Other cells [#/volume] in Blood by Manual count

136

0.71

0.44

2.1

1.5

0.40

0.50

e9/l

—

136

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

168

1.26

0.44

1.1

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

261

2672

0.94

0.43

3.6

3.7

1.31

1.61

0.70

231

2377

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

337

1.17

0.42

3.8

2.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.43

0.42

1.1

252.12

241.85

nmol/l

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.43

0.42

6.9

6.6

439.50

442.50

umol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

355

1.17

0.42

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

108

948

1.10

0.42

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

151

1347

1.08

0.42

1.8

1.5

29.78

27.07

0.45

109

854

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

233

2113

1.06

0.41

1.1

76.90

479.85

iu/ml

0.66

395

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

118

1.31

0.41

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

383

1.16

0.41

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

125

1108

1.09

0.40

1.0

321.17

313.87

ng/l

0.12

790

(3023430) Cat dander IgE Ab [Units/volume] in Serum

128

1136

1.09

0.40

1.1

2.71

3.96

u/ml

0.52

506

(4211845) Urine protein measurement

633

0.88

0.40

2.7

3.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

171

1.24

0.39

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

403

1.15

0.39

1.0

1.1

0.38

2.50

u/ml

0.71

102

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

385

1.15

0.39

1.1

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

495

4591

1.04

0.38

1.7

1.8

—

(40758292) HTLV I+II Ab panel - Serum

260

0.82

0.38

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

309

2835

1.05

0.38

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.38

0.38

3.6

5.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

560

1.12

0.37

8.7

7.6

29.33

201.63

ug/l

1.63

392

(3001019) Free T4 and TSH panel - Serum or Plasma

376

3472

1.05

0.36

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

598

0.89

0.36

1.5

50.77

59.93

ug/l

1.82

598

(3012898) Urea [Moles/volume] in Urine

173

0.78

0.35

1.1

1.4

120.74

173.69

mmol/l

1.26

148

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

124

1289

0.93

0.35

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

156

1408

1.07

0.34

1.1

1.00

1.17

u/ml

0.15

716

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

167

1511

1.07

0.34

2.0

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2874

28089

0.98

0.34

1.8

33583691.61

31757433.06

pmol/l

0.06

2534

23113

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.34

0.34

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

166

1.22

0.34

2.1

3.3

1.77

1.26

mg/l

0.59

129

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

124

1111

1.08

0.33

1.0

787.09

720.59

ng/l

0.91

775

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.32

0.33

1.7

1.3

779.37

511.89

nmol/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

124

1113

1.08

0.32

1.0

41.97

40.53

ng/l

0.15

780

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

470

0.88

0.32

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

742

1.09

0.32

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

132

1.24

0.32

1.1

2.9

8.11

6.85

mmol/l

—

(3028626) Oxygen [Partial pressure] in Capillary blood

423

4232

0.96

0.32

4.7

3.4

8.08

8.02

kpa

0.30

413

4126

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

280

2826

0.95

0.31

1.2

1.1

0.60

0.64

ratio

0.59

462

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.22

0.31

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

263

0.84

0.31

2.0

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.27

0.30

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

147

0.79

0.29

1.5

1.2

4.34

6.91

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

178

1.19

0.29

1.1

1.0

23.58

38.32

iu/ml

1.41

178

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

143

1.21

0.28

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

165

1507

1.06

0.28

2.5

2.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

403

0.89

0.28

1.1

4.53

3.85

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

392

0.89

0.27

1.6

3584.00

3437.65

titre

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

189

1.17

0.27

1.0

1.3

40.04

47.60

mg/l

0.31

160

(3006462) Nitrate [Presence] in Urine

573

0.91

0.26

2.7

3.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.28

0.26

2.4

5.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

390

0.89

0.25

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

174

1761

0.95

0.24

1.7

1.5

57.28

62.51

1.07

124

1137

(3026692) Albumin [Mass/volume] in Peritoneal fluid

476

1.09

0.24

1.5

10.98

13.43

g/l

1.14

357

(4281824) Cell count and differential, peritoneal fluid

808

0.93

0.23

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

784

1.07

0.23

2.1

2.2

66.78

145.78

ug/min

1.24

192

(3000285) Sodium [Moles/volume] in Blood

283

1.13

0.23

1.2

139.14

138.81

mmol/l

0.16

238

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.34

0.23

1.2

1.1

1.60

3.06

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

201

1.15

0.23

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

628

0.92

0.23

2.3

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

192

1933

0.96

0.23

4.4

5.0

332.47

347.67

umol/l

0.87

170

1654

(3037121) Protein [Mass/volume] in Urine

494

4886

0.97

0.22

3.5

399.31

528.89

mg/l

0.86

280

2504

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.21

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.21

0.0

2.9

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

685

1.07

0.21

1.3

1.8

3.88

2.96

u/field

0.23

487

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.21

1.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.25

0.20

1.0

1.1

0.03

0.05

u/ml

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

2023

0.96

0.20

1.6

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5583

53564

1.01

0.20

4.2

45.24

86.22

ng/l

3.69

4161

41797

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.20

0.0

2.4

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.13

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

0.80

0.20

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

250

1.12

0.20

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

105

960

1.06

0.19

1.4

28.46

22.22

u/l

0.96

792

(3026470) Cobalt [Mass/volume] in Blood

103

1046

0.95

0.19

2.1

2.2

3.09

3.42

ug/l

0.36

966

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

114

1048

1.05

0.18

1.0

0.62

0.45

u/ml

0.14

370

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

717

0.94

0.17

1.8

—

(3021788) Differential panel - Synovial fluid

290

2723

1.03

0.17

1.6

1.5

—

0.89

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.71

0.16

1.2

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

152

1.14

0.16

2.2

1.9

0.81

1.51

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.17

0.16

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.17

0.16

1.0

1.1

35.70

36.62

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.17

0.16

1.0

8.86

8.65

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.17

0.16

1.0

1.1

19.49

21.66

—

(3025577) Chromium [Mass/volume] in Blood

100

1011

0.95

0.16

2.3

2.2

1.86

2.03

ug/l

0.45

833

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

145

1347

1.04

0.16

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

145

1347

1.04

0.16

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

145

1347

1.04

0.16

1.8

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

366

1.08

0.16

1.4

1.2

—

(3000012) Reticulocyte production index

264

2479

1.03

0.15

2.0

2.3

0.90

0.93

0.41

201

1745

(3008295) Osmolality of Serum or Plasma

158

1472

1.04

0.15

1.3

1.4

278.92

278.93

mosm/kgh2o

0.00

124

1153

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.79

0.14

1.4

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

1047

1.04

0.14

1.9

1.8

1.03

1.37

u/field

0.58

580

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.78

0.14

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

145

1.13

0.14

1.6

2.5

0.35

u/field

0.00

145

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1030

9823

1.01

0.14

2.1

3.66

3.57

ratio

1.12

836

7964

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.83

0.13

1.0

—

(21494755) Public health laboratory ask at order entry panel

815

7962

0.99

0.13

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

174

0.89

0.13

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

174

0.89

0.13

1.1

2.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

184

0.89

0.13

1.2

1.1

22.50

19.27

u/l

—

119

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

130

1298

0.97

0.13

1.3

172.01

172.55

pmol/l

0.02

130

1298

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

233

2196

1.02

0.12

2.4

2.3

32.61

32.76

0.21

233

2183

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

653

6217

1.01

0.12

1.5

—

(40765096) Chromosome analysis panel by Banding

488

0.95

0.11

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

141

0.89

0.10

2.0

2.9

41.15

43.06

0.13

141

(3014133) Dog dander IgE Ab [Units/volume] in Serum

129

1209

1.03

0.10

1.1

2.28

3.07

u/ml

0.64

604

(42870560) Thyrotropin [Units/volume] in Cord blood

1.15

0.10

1.0

9.74

9.63

mu/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

280

1.07

0.10

1.8

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.12

0.10

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

150

0.90

0.09

2.1

1.7

61.29

44.45

umol/l

0.77

150

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

140

0.90

0.09

4.0

5.9

13.54

8.19

1.37

140

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

281

1.06

0.09

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

687

6688

0.99

0.08

2.2

0.01

0.17

estimate

0.61

281

1759

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.79

0.08

1.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.79

0.08

1.8

1.6

16.20

23.01

nmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

216

1.07

0.08

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

349

1.05

0.08

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

108

1016

1.03

0.07

1.2

385.18

339.81

nmol/l

1.20

829

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

151

1.09

0.07

1.0

1.6

1.74

2.19

ug/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.04

0.07

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

108

1017

1.02

0.07

1.8

1.7

415.23

331.26

mu/l

0.61

794

(3044009) aPTT.lupus sensitive (LA screen)

0.84

0.07

1.4

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.84

0.07

1.9

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

667

0.97

0.07

1.3

1.2

—

(3019174) dRVVT (LA screen)

0.82

0.07

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

314

3066

0.99

0.07

1.2

1.49

1.48

g/l

0.24

314

3066

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

199

1.07

0.06

4.9

5.9

68.00

53.53

ug/min

0.28

171

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

304

1.05

0.06

1.5

1.8

2.80

2.70

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

144

1412

0.98

0.05

1.3

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

244

0.95

0.05

1.1

1.0

10.85

10.33

u/ml

0.03

147

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

544

1.03

0.05

1.1

134.79

586.52

ng/l

1.96

156

(3029396) Erythrocyte agglutination [Presence] in Blood

106

1.09

0.05

3.2

2.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

106

0.91

0.05

3.7

2.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

141

1340

1.02

0.05

1.2

6.96

7.66

mmol/l

2.23

123

1138

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

164

0.94

0.04

1.1

1.2

114.33

101.31

ug/l

—

101

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

104

0.93

0.02

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

262

1.03

0.02

4.0

6.0

8.90

8.63

mmol/l

0.20

262

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

378

1.02

0.01

1.5

1.8

10.23

160.14

pmol/l

0.57

101

(40768806) Pleura Pathology biopsy report

203

1969

0.99

0.01

1.5

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

715

6909

1.00

0.01

1.8

3.36

3.39

mmol/l

0.28

520

4985

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

145

1.00

0.00

1.5

2.4

46.63

59.24

—

(3038026) Centromere Ab [Units/volume] in Serum

938

1.00

0.00

1.2

87.61

38.26

u/ml

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

397

1.00

0.00

1.1

1.2

22.57

22.00

—

(3020650) Glucose [Presence] in Urine

405

1.00

0.00

2.1

1.6

0.00

0.06

estimate

2.48

405

(3016330) Potassium [Moles/time] in 24 hour Urine

167

0.98

0.00

1.2

1.3

—

92.87

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

189

1.02

0.00

1.7

1.2

41.10

52.96

—

(3011897) Casein IgE Ab [Units/volume] in Serum

117

0.99

0.00

1.1

1.2

0.24

0.82

u/ml

0.73

117

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.96

0.00

6.2

6.3

1.30

1.15

mg/l

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.0

1.3

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.16

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.91

-0.00

1.6

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

39.22

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.89

-0.00

1.0

1.2

1.27

1.34

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ABNORMAL_SERUM_ENZYME_LEVELS – Abnormal serum enzyme levels

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Abnormal serum enzyme levels

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Abnormal serum enzyme levels (R18_ABNORMAL_SERUM_ENZYME_LEVELS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints